Characterization	O
of	O
a	O
new	O
isoform	O
of	O
the	O
NFAT	B-protein
(	O
nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cells	I-protein
)	O
gene	O
family	O
member	O
NFATc	B-protein
[	O
published	O
erratum	O
appears	O
in	O
J	O
Biol	O
Chem	O
1996	O
Dec	O
27	O
;	O
271	O
(	O
52	O
)	O
:	O
33705	O
]	O

The	O
cyclosporin	B-protein
A	I-protein
(	I-protein
CsA	I-protein
)	I-protein
/FK506-sensitive	I-protein
nuclear	I-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cells	I-protein
(	O
NFAT	B-protein
)	O
plays	O
a	O
key	O
role	O
in	O
the	O
inducible	O
expression	O
of	O
cytokine	B-DNA
genes	I-DNA
in	O
T	B-cell_type
cells	I-cell_type
.	O

Although	O
NFAT	B-protein
has	O
been	O
recently	O
shown	O
to	O
be	O
inducible	O
in	O
several	O
non-T	B-cell_type
immune	I-cell_type
cells	I-cell_type
,	O
the	O
NFAT	B-DNA
gene	I-DNA
family	I-DNA
members	I-DNA
characterized	O
to	O
date	O
have	O
been	O
isolated	O
only	O
from	O
T	B-cell_type
cells	I-cell_type
.	O

To	O
further	O
characterize	O
NFAT	B-protein
function	O
in	O
human	B-cell_type
B	I-cell_type
cells	I-cell_type
and	O
to	O
demonstrate	O
cytokine	O
gene	O
specificity	O
of	O
NFAT	B-protein
proteins	I-protein
,	O
we	O
report	O
here	O
the	O
isolation	O
and	O
characterization	O
of	O
a	O
cDNA	B-DNA
clone	I-DNA
from	O
the	O
Raji	B-cell_line
B	I-cell_line
cell	I-cell_line
line	I-cell_line
.	O

The	O
cDNA	B-DNA
clone	I-DNA
encodes	O
a	O
new	O
isoform	O
,	O
NFATc.beta	B-protein
,	O
of	O
the	O
NFAT	B-protein
gene	I-protein
family	I-protein
member	I-protein
NFATc	B-protein
(	O
designated	O
here	O
NFATc.alpha	B-protein
)	O
.	O

The	O
amino	B-protein
acid	I-protein
sequence	I-protein
of	O
NFATc.beta	B-protein
differs	O
from	O
that	O
of	O
NFATc	B-protein
.	O

alpha	O
in	O
the	O
first	O
NH2-terminal	B-protein
29	I-protein
residues	I-protein
and	O
contains	O
an	O
additional	O
region	O
of	O
142	B-protein
residues	I-protein
at	O
the	O
COOH	B-protein
terminus	I-protein
.	O

Northern	O
analysis	O
using	O
a	O
probe	O
encompassing	O
a	O
common	O
region	O
of	O
both	O
isoforms	O
showed	O
two	O
mRNA	B-RNA
species	I-RNA
of	O
2.7	B-RNA
and	I-RNA
4.5	I-RNA
kilobase	I-RNA
pairs	I-RNA
,	O
while	O
an	O
NFATc.beta-specific	B-DNA
probe	I-DNA
detected	O
only	O
the	O
4.5-kilobase	B-RNA
pair	I-RNA
mRNA	I-RNA
which	O
was	O
preferentially	O
expressed	O
in	O
the	O
spleen	O
.	O

Transient	O
expression	O
of	O
NFATc.beta	B-protein
was	O
capable	O
of	O
activating	O
an	O
interleukin-2	B-DNA
NFAT-driven	I-DNA
reporter	I-DNA
gene	I-DNA
in	O
stimulated	B-cell_line
Jurkat	I-cell_line
cells	I-cell_line
in	O
a	O
CsA-sensitive	O
manner	O
.	O

However	O
,	O
NFATc.beta	B-protein
neither	O
bound	O
to	O
the	O
kappa3	B-DNA
element	I-DNA
(	O
an	O
NFAT-binding	B-DNA
site	I-DNA
)	O
in	O
the	O
tumor	B-DNA
necrosis	I-DNA
factor-alpha	I-DNA
promoter	I-DNA
nor	O
activated	O
the	O
tumor	B-DNA
necrosis	I-DNA
factor-alpha	I-DNA
promoter	I-DNA
in	O
cotransfection	O
assays	O
.	O

These	O
data	O
suggest	O
that	O
different	O
members	O
or	O
isoforms	O
of	O
NFAT	B-DNA
gene	I-DNA
family	O
may	O
regulate	O
inducible	O
expression	O
of	O
different	O
cytokine	B-DNA
genes	I-DNA
.	O

THz	NULL
JourNat	NULL
or	NULL
BioLoGIcaL	NULL
CHEMISTRY	NULL
©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

271	NULL
,	NULL
No	NULL
.	NULL

34	NULL
,	NULL
Issue	NULL
of	NULL
August	NULL
23	NULL
,	NULL
pp	NULL
.	NULL

20914-20921	NULL
,	NULL
1996	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

Characterization	NULL
of	NULL
a	NULL
New	NULL
Isoform	NULL
of	NULL
the	NULL
NFAT	NULL
(	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
Cells	NULL
)	NULL
Gene	NULL
Family	NULL
Member	NULL
NFATc*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
April	NULL
22	NULL
,	NULL
1996	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
June	NULL
6	NULL
,	NULL
1996	NULL
)	NULL
Jungchan	NULL
Park	NULL
,	NULL
Atsuko	NULL
Takeuchi	NULL
,	NULL
and	NULL
Surendra	NULL
Sharma	NULL
#	NULL
From	NULL
the	NULL
Section	NULL
of	NULL
Experimental	NULL
Pathology	NULL
,	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
Roger	NULL
Williams	NULL
Medical	NULL
Center-Brown	NULL
University	NULL
,	NULL
Providence	NULL
,	NULL
Rhode	NULL
Island	NULL
02908	NULL
The	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
/FK506-sensitive	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
plays	NULL
a	NULL
key	NULL
role	NULL
in	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
cytokine	NULL
genes	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Although	NULL
NFAT	NULL
has	NULL
been	NULL
recently	NULL
shown	NULL
to	NULL
be	NULL
inducible	NULL
in	NULL
several	NULL
non-T	NULL
immune	NULL
cells	NULL
,	NULL
the	NULL
NFAT	NULL
gene	NULL
family	NULL
members	NULL
characterized	NULL
to	NULL
date	NULL
have	NULL
been	NULL
isolated	NULL
only	NULL
from	NULL
T	NULL
cells	NULL
.	NULL

To	NULL
further	NULL
characterize	NULL
NFAT	NULL
function	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
and	NULL
to	NULL
demonstrate	NULL
cytokine	NULL
gene	NULL
specificity	NULL
of	NULL
NFAT	NULL
proteins	NULL
,	NULL
we	NULL
report	NULL
here	NULL
the	NULL
isolation	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
cDNA	NULL
clone	NULL
from	NULL
the	NULL
Raji	NULL
B	NULL
cell	NULL
line	NULL
.	NULL

The	NULL
cDNA	NULL
clone	NULL
encodes	NULL
a	NULL
new	NULL
isoform	NULL
,	NULL
NFATe.B	NULL
,	NULL
of	NULL
the	NULL
NFAT	NULL
gene	NULL
family	NULL
member	NULL
NFATec	NULL
(	NULL
designated	NULL
here	NULL
NFATc.a	NULL
)	NULL
.	NULL

The	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
NFATe.f	NULL
differs	NULL
from	NULL
that	NULL
of	NULL
NFATc	NULL
.	NULL

«	NULL
in	NULL
the	NULL
first	NULL
NH	NULL
,	NULL
-terminal	NULL
29	NULL
residues	NULL
and	NULL
contains	NULL
an	NULL
additional	NULL
region	NULL
of	NULL
142	NULL
residues	NULL
at	NULL
the	NULL
COOH	NULL
terminus	NULL
.	NULL

Northern	NULL
analysis	NULL
using	NULL
a	NULL
probe	NULL
encompassing	NULL
a	NULL
common	NULL
region	NULL
of	NULL
both	NULL
isoforms	NULL
showed	NULL
two	NULL
mRNA	NULL
species	NULL
of	NULL
2.7	NULL
and	NULL
4.5	NULL
kilobase	NULL
pairs	NULL
,	NULL
while	NULL
an	NULL
NFATe.B-specific	NULL
probe	NULL
detected	NULL
only	NULL
the	NULL
4.5-kilobase	NULL
pair	NULL
mRNA	NULL
which	NULL
was	NULL
preferentially	NULL
expressed	NULL
in	NULL
the	NULL
spleen	NULL
.	NULL

Transient	NULL
expression	NULL
of	NULL
NFATe.B	NULL
was	NULL
capable	NULL
of	NULL
activating	NULL
an	NULL
interleukin-2	NULL
NFAT-driven	NULL
reporter	NULL
gene	NULL
in	NULL
stimulated	NULL
Jurkat	NULL
cells	NULL
in	NULL
a	NULL
CsA-sensitive	NULL
manner	NULL
.	NULL

However	NULL
,	NULL
NFATc	NULL
.	NULL

#	NULL
neither	NULL
bound	NULL
to	NULL
the	NULL
«	NULL
3	NULL
element	NULL
(	NULL
an	NULL
NFAT	NULL
-binding	NULL
site	NULL
)	NULL
in	NULL
the	NULL
tumor	NULL
necrosis	NULL
fac-tor-	NULL
«	NULL
promoter	NULL
nor	NULL
activated	NULL
the	NULL
tumor	NULL
necrosis	NULL
fac-tor-	NULL
«	NULL
promoter	NULL
in	NULL
cotransfection	NULL
assays	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
different	NULL
members	NULL
or	NULL
isoforms	NULL
of	NULL
NFAT	NULL
gene	NULL
family	NULL
may	NULL
regulate	NULL
inducible	NULL
expression	NULL
of	NULL
different	NULL
cytokine	NULL
genes	NULL
.	NULL

Nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
is	NULL
a	NULL
multicompo-nent	NULL
transcription	NULL
factor	NULL
regulating	NULL
expression	NULL
of	NULL
several	NULL
cytokine	NULL
genes	NULL
in	NULL
antigen-activated	NULL
T	NULL
cells	NULL
and	NULL
functions	NULL
as	NULL
a	NULL
major	NULL
molecular	NULL
target	NULL
for	NULL
the	NULL
immunosuppressive	NULL
drugs	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
and	NULL
FK506	NULL
(	NULL
reviewed	NULL
in	NULL
Refs	NULL
.	NULL

1-3	NULL
)	NULL
.	NULL

It	NULL
consists	NULL
of	NULL
a	NULL
protein	NULL
kinase	NULL
C-inducible	NULL
nuclear	NULL
component	NULL
and	NULL
a	NULL
pre-existing	NULL
cytoplasmic	NULL
component	NULL
(	NULL
s	NULL
)	NULL
whose	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
is	NULL
dependent	NULL
upon	NULL
Ca*	NULL
``	NULL
*	NULL
mobilization	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

The	NULL
protein	NULL
kinase	NULL
C-inducible	NULL
nuclear	NULL
component	NULL
was	NULL
found	NULL
to	NULL
be	NULL
AP-1	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
CA55910	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
(	NULL
s	NULL
)	NULL
reported	NULL
in	NULL
this	NULL
paper	NULL
has	NULL
been	NULL
submitted	NULL
to	NULL
the	NULL
GenBank	NULL
``	NULL
/EBI	NULL
Data	NULL
Bank	NULL
with	NULL
accession	NULL
number	NULL
(	NULL
s	NULL
)	NULL
U59736	NULL
.	NULL
}	NULL

To	NULL
whom	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
401-456-6565	NULL
;	NULL
Fax	NULL
:	NULL
401-456-6569	NULL
.	NULL

*The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
NFAT	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
;	NULL
CsA	NULL
,	NULL
cyclosporin	NULL
A	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
18-acetate	NULL
;	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
TNF	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
;	NULL
Ig	NULL
,	NULL
immunoglobulin	NULL
;	NULL
hGH	NULL
,	NULL
human	NULL
growth	NULL
hormone	NULL
;	NULL
PAGE	NULL
,	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
kb	NULL
,	NULL
kilobase	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
.	NULL

proteins	NULL
(	NULL
6	NULL
)	NULL
,	NULL
and	NULL
several	NULL
members	NULL
of	NULL
the	NULL
Fos	NULL
and	NULL
Jun	NULL
families	NULL
have	NULL
been	NULL
described	NULL
to	NULL
participate	NULL
in	NULL
NFAT	NULL
complexes	NULL
,	NULL
contributing	NULL
to	NULL
NFAT-dependent	NULL
transcription	NULL
(	NULL
7-10	NULL
)	NULL
.	NULL

Although	NULL
an	NULL
investigation	NULL
of	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
led	NULL
to	NULL
the	NULL
primary	NULL
characterization	NULL
of	NULL
NFAT	NULL
complex	NULL
,	NULL
functional	NULL
NFAT	NULL
binding	NULL
sites	NULL
have	NULL
also	NULL
been	NULL
identified	NULL
in	NULL
the	NULL
regulatory	NULL
regions	NULL
of	NULL
other	NULL
cytokine	NULL
genes	NULL
,	NULL
including	NULL
IL-3/granulocyte/	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
,	NULL
IL-4	NULL
(	NULL
13-15	NULL
)	NULL
,	NULL
IL-5	NULL
(	NULL
16	NULL
)	NULL
,	NULL
and	NULL
TNF-a	NULL
(	NULL
17	NULL
)	NULL
,	NULL
whose	NULL
expression	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
CsA-sensitive	NULL
.	NULL

Recently	NULL
several	NULL
cytoplasmic	NULL
components	NULL
of	NULL
NFAT	NULL
,	NULL
collectively	NULL
termed	NULL
NFAT	NULL
family	NULL
proteins	NULL
,	NULL
have	NULL
been	NULL
cloned	NULL
and	NULL
characterized	NULL
in	NULL
murine	NULL
and	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

They	NULL
include	NULL
NFATp	NULL
(	NULL
18	NULL
)	NULL
,	NULL
NFATc	NULL
(	NULL
19	NULL
)	NULL
,	NULL
NFATx/NFAT4/NFATc3	NULL
(	NULL
20-22	NULL
)	NULL
,	NULL
and	NULL
NFAT3	NULL
(	NULL
21	NULL
)	NULL
and	NULL
share	NULL
a	NULL
conserved	NULL
region	NULL
of	NULL
~290	NULL
amino	NULL
acids	NULL
.	NULL

This	NULL
region	NULL
exhibits	NULL
DNA	NULL
binding	NULL
activity	NULL
and	NULL
shows	NULL
a	NULL
limited	NULL
sequence	NULL
similarity	NULL
to	NULL
the	NULL
DNA	NULL
binding	NULL
and	NULL
dimeriza-tion	NULL
domains	NULL
of	NULL
dorsal/rel/NFkB	NULL
transcription	NULL
factors	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

23	NULL
)	NULL
.	NULL

Another	NULL
common	NULL
feature	NULL
of	NULL
these	NULL
proteins	NULL
is	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
repeated	NULL
motifs	NULL
of	NULL
serine-proline	NULL
residues	NULL
(	NULL
SPXXSPXXSPXXXXX	NULL
(	NULL
D/E	NULL
)	NULL
(	NULL
D/E	NULL
)	NULL
)	NULL
in	NULL
the	NULL
region	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Most	NULL
(	NULL
if	NULL
not	NULL
all	NULL
)	NULL
NFAT	NULL
family	NULL
proteins	NULL
appear	NULL
to	NULL
undergo	NULL
dephosphorylation	NULL
in	NULL
response	NULL
to	NULL
stimuli	NULL
increasing	NULL
intracellu-lar	NULL
Ca**	NULL
concentration	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
they	NULL
are	NULL
either	NULL
direct	NULL
or	NULL
indirect	NULL
substrates	NULL
for	NULL
the	NULL
Ca**/calmodulin-de-pendent	NULL
phosphatase	NULL
calcineurin	NULL
which	NULL
is	NULL
sensitive	NULL
to	NULL
the	NULL
immunosuppressive	NULL
drugs	NULL
CsA	NULL
and	NULL
FK506	NULL
.	NULL

For	NULL
example	NULL
,	NULL
NFATp	NULL
acts	NULL
as	NULL
an	NULL
in	NULL
vitro	NULL
substrate	NULL
of	NULL
calcineurin	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
and	NULL
becomes	NULL
dephosphorylated	NULL
upon	NULL
treatment	NULL
with	NULL
ionomycin	NULL
prior	NULL
to	NULL
its	NULL
nuclear	NULL
translocation	NULL
.	NULL

This	NULL
dephosphorylation	NULL
process	NULL
is	NULL
blocked	NULL
by	NULL
CsA	NULL
and	NULL
FK506	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
phosphorylated	NULL
NFATp	NULL
fails	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
IL-2	NULL
NFAT	NULL
binding	NULL
site	NULL
,	NULL
suggesting	NULL
that	NULL
CsA	NULL
not	NULL
only	NULL
affects	NULL
nuclear	NULL
translocation	NULL
but	NULL
also	NULL
DNA	NULL
binding	NULL
ability	NULL
of	NULL
NFAT	NULL
family	NULL
proteins	NULL
(	NULL
26	NULL
)	NULL
.	NULL

It	NULL
has	NULL
recently	NULL
become	NULL
clear	NULL
that	NULL
NFAT	NULL
also	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
production	NULL
of	NULL
cytokines	NULL
by	NULL
non-T	NULL
cells	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Although	NULL
originally	NULL
described	NULL
as	NULL
a	NULL
T	NULL
cell-specific	NULL
transcriptional	NULL
factor	NULL
,	NULL
NFAT	NULL
proteins	NULL
,	NULL
in	NULL
particular	NULL
NFATp	NULL
,	NULL
have	NULL
been	NULL
detected	NULL
in	NULL
several	NULL
other	NULL
hematopoietic	NULL
cells	NULL
including	NULL
B	NULL
cells	NULL
(	NULL
27-29	NULL
)	NULL
,	NULL
natural	NULL
killer	NULL
cells	NULL
(	NULL
30	NULL
)	NULL
,	NULL
mast	NULL
cells	NULL
(	NULL
31	NULL
)	NULL
,	NULL
and	NULL
macrophages	NULL
(	NULL
5	NULL
)	NULL
as	NULL
well	NULL
as	NULL
in	NULL
neuronal	NULL
cells	NULL
(	NULL
32	NULL
)	NULL
albeit	NULL
with	NULL
no	NULL
well	NULL
defined	NULL
function	NULL
.	NULL

We	NULL
have	NULL
been	NULL
characterizing	NULL
NFAT	NULL
function	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
and	NULL
showed	NULL
that	NULL
B	NULL
cell	NULL
NFAT	NULL
complex	NULL
was	NULL
indistinguishable	NULL
from	NULL
that	NULL
detected	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
9	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
CsA	NULL
leads	NULL
to	NULL
phos-phorylation	NULL
of	NULL
nuclear	NULL
NFATp	NULL
in	NULL
transformed	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
and	NULL
inhibits	NULL
its	NULL
DNA	NULL
binding	NULL
(	NULL
26	NULL
)	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
CsA	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
directly	NULL
inhibit	NULL
B	NULL
cell	NULL
activation	NULL
elicited	NULL
by	NULL
anti-lg	NULL
,	NULL
SAC	NULL
,	NULL
or	NULL
ionomycin	NULL
which	NULL
induce	NULL
Ca**	NULL
mobilization	NULL
during	NULL
the	NULL
signaling	NULL
processes	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

33	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
it	NULL
also	NULL
prevents	NULL
TNF-a	NULL
production	NULL
by	NULL
B	NULL
cells	NULL
stimulated	NULL
through	NULL
their	NULL
surface	NULL
Ig	NULL
receptor	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
murine	NULL
T	NULL
cells	NULL
,	NULL
a	NULL
20914	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Transcription	NULL
Factor	NULL
NFAT	NULL
Gene	NULL
Family	NULL
transcription	NULL
factor	NULL
similar	NULL
or	NULL
identical	NULL
to	NULL
NFATp	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
CsA-sensitive	NULL
regulatory	NULL
element	NULL
(	NULL
«	NULL
3	NULL
element	NULL
)	NULL
in	NULL
the	NULL
TNF-a	NULL
promoter	NULL
(	NULL
17	NULL
,	NULL
35	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
NFAT	NULL
appears	NULL
to	NULL
mediate	NULL
CsA-sensitive	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
TNF-a	NULL
and	NULL
other	NULL
yet	NULL
unidentified	NULL
,	NULL
activation-associated	NULL
genes	NULL
in	NULL
B	NULL
cells	NULL
by	NULL
similar	NULL
mechanisms	NULL
operational	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

To	NULL
further	NULL
understand	NULL
the	NULL
structural	NULL
complexity	NULL
and	NULL
function	NULL
of	NULL
NFAT	NULL
,	NULL
we	NULL
screened	NULL
a	NULL
cDNA	NULL
library	NULL
derived	NULL
from	NULL
Raji	NULL
B	NULL
cells	NULL
to	NULL
isolate	NULL
a	NULL
unique	NULL
NFAT	NULL
family	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
report	NULL
cDNA	NULL
cloning	NULL
and	NULL
initial	NULL
characterization	NULL
of	NULL
a	NULL
new	NULL
isoform	NULL
,	NULL
designated	NULL
NFATc.B	NULL
of	NULL
NFAT	NULL
family	NULL
member	NULL
NFATec	NULL
.	NULL

«	NULL
.	NULL
``	NULL

This	NULL
molecule	NULL
exhibits	NULL
a	NULL
unique	NULL
expression	NULL
pattern	NULL
and	NULL
likely	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
the	NULL
mutually	NULL
exclusive	NULL
expression	NULL
of	NULL
cytokine	NULL
genes	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
cDNA	NULL
Cloning-A	NULL
cDNA	NULL
library	NULL
constructed	NULL
in	NULL
Agt10	NULL
vector	NULL
was	NULL
purchased	NULL
from	NULL
Clontech	NULL
Inc.	NULL
(	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
was	NULL
derived	NULL
from	NULL
a	NULL
human	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
line	NULL
Raji	NULL
using	NULL
both	NULL
random	NULL
and	NULL
oli-go	NULL
(	NULL
dT	NULL
)	NULL
primers	NULL
.	NULL

The	NULL
cDNA	NULL
library	NULL
was	NULL
screened	NULL
under	NULL
low	NULL
stringency	NULL
conditions	NULL
using	NULL
a	NULL
radiolabeled	NULL
DNA	NULL
fragment	NULL
corresponding	NULL
to	NULL
nucleotides	NULL
1-1257	NULL
in	NULL
the	NULL
published	NULL
murine	NULL
NFAT	NULL
p	NULL
sequence	NULL
(	NULL
18	NULL
)	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

The	NULL
DNA	NULL
probe	NULL
contained	NULL
NH	NULL
,	NULL
-terminal	NULL
of	NULL
the	NULL
rel	NULL
similarity	NULL
domain	NULL
and	NULL
its	NULL
upstream	NULL
sequence	NULL
.	NULL

This	NULL
was	NULL
obtained	NULL
from	NULL
murine	NULL
NFATp	NULL
cDNA	NULL
clone	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Drs	NULL
.	NULL

A.	NULL
Rao	NULL
and	NULL
P.	NULL
Hogan	NULL
)	NULL
by	NULL
double	NULL
digestion	NULL
with	NULL
HindIII	NULL
and	NULL
Accel	NULL
.	NULL

Positive	NULL
clones	NULL
were	NULL
isolated	NULL
by	NULL
three	NULL
rounds	NULL
of	NULL
hybridization	NULL
,	NULL
and	NULL
inserts	NULL
were	NULL
subcloned	NULL
into	NULL
Bluescript	NULL
plasmids	NULL
.	NULL

The	NULL
clone	NULL
containing	NULL
the	NULL
longest	NULL
cDNA	NULL
insert	NULL
was	NULL
sequenced	NULL
on	NULL
both	NULL
strands	NULL
using	NULL
the	NULL
dideoxynucleotide	NULL
chain	NULL
termination	NULL
(	NULL
U.	NULL
S.	NULL
Biochemical	NULL
Corp.	NULL
)	NULL
and	NULL
polymerase	NULL
chain	NULL
reaction	NULL
sequencing	NULL
(	NULL
Pro-mega	NULL
)	NULL
methods	NULL
.	NULL

Northern	NULL
Blots-A	NULL
Northern	NULL
blot	NULL
with	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*®	NULL
RNAs	NULL
isolated	NULL
from	NULL
multiple	NULL
human	NULL
tissues	NULL
was	NULL
purchased	NULL
from	NULL
Clontech	NULL
Inc.	NULL
For	NULL
the	NULL
common	NULL
probe	NULL
of	NULL
NFATe.a	NULL
and	NULL
NFATe.B	NULL
,	NULL
we	NULL
used	NULL
a	NULL
467-base	NULL
pair	NULL
Nsil-Neo	NULL
!	NULL

fragment	NULL
of	NULL
a	NULL
NFATe.f	NULL
cDNA	NULL
clone	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
of	NULL
this	NULL
fragment	NULL
is	NULL
identical	NULL
between	NULL
NFATe	NULL
.	NULL

«	NULL
and	NULL
and	NULL
corresponds	NULL
to	NULL
nucleotides	NULL
383-848	NULL
in	NULL
the	NULL
published	NULL
NFATe	NULL
.	NULL

«	NULL
cDNA	NULL
sequence	NULL
(	NULL
19	NULL
)	NULL
and	NULL
to	NULL
nucleotides	NULL
180-646	NULL
in	NULL
the	NULL
NFATe.6	NULL
cDNA	NULL
of	NULL
this	NULL
study	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

For	NULL
the	NULL
NFATe.6	NULL
unique	NULL
probe	NULL
,	NULL
we	NULL
used	NULL
a	NULL
418-base	NULL
pair	NULL
polymerase	NULL
chain	NULL
reaction	NULL
fragment	NULL
encompassing	NULL
the	NULL
region	NULL
encoding	NULL
amino	NULL
acids	NULL
676-814	NULL
located	NULL
downstream	NULL
of	NULL
the	NULL
rel	NULL
similarity	NULL
domain	NULL
of	NULL
NFATe.B	NULL
.	NULL

The	NULL
human	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
cDNA	NULL
probe	NULL
was	NULL
used	NULL
to	NULL
quantitate	NULL
the	NULL
amounts	NULL
of	NULL
RNA	NULL
loaded	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

DNA	NULL
probes	NULL
were	NULL
labeled	NULL
by	NULL
random	NULL
priming	NULL
and	NULL
hybridization	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
5	NULL
X	NULL
SSPE	NULL
,	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
5	NULL
x	NULL
Denhardt	NULL
's	NULL
solution	NULL
,	NULL
2	NULL
%	NULL
SDS	NULL
,	NULL
100	NULL
ug/ml	NULL
herring	NULL
sperm	NULL
DNA	NULL
at	NULL
42	NULL
°C	NULL
.	NULL

The	NULL
filter	NULL
was	NULL
washed	NULL
in	NULL
2	NULL
x	NULL
SSC	NULL
,	NULL
0.05	NULL
%	NULL
SDS	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
and	NULL
subsequently	NULL
in	NULL
0.1	NULL
x	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
at	NULL
55	NULL
°C	NULL
.	NULL

The	NULL
same	NULL
filter	NULL
was	NULL
used	NULL
for	NULL
all	NULL
subsequent	NULL
hybridizations	NULL
.	NULL

Generation	NULL
of	NULL
Recombinant	NULL
Proteins	NULL
and	NULL
Purification-Escherichia	NULL
coli	NULL
expression	NULL
plasmids	NULL
for	NULL
three	NULL
deletion	NULL
derivatives	NULL
of	NULL
proteins	NULL
were	NULL
constructed	NULL
into	NULL
pQE30	NULL
(	NULL
Qaigen	NULL
,	NULL
CA	NULL
)	NULL
by	NULL
subcloning	NULL
the	NULL
NFATe.6	NULL
cDNA	NULL
fragments	NULL
,	NULL
which	NULL
express	NULL
recombinant	NULL
proteins	NULL
tagged	NULL
with	NULL
a	NULL
hexahistidine	NULL
at	NULL
the	NULL
NH	NULL
,	NULL
terminus	NULL
.	NULL

Using	NULL
the	NULL
cDNA	NULL
clone	NULL
as	NULL
template	NULL
,	NULL
a	NULL
polymerase	NULL
chain	NULL
reaction	NULL
fragment	NULL
was	NULL
generated	NULL
with	NULL
5'-	NULL
and	NULL
3'-primers	NULL
containing	NULL
restriction	NULL
linker	NULL
sites	NULL
,	NULL
BamHI	NULL
and	NULL
Kpnl	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
subsequently	NULL
the	NULL
restricted	NULL
polymerase	NULL
chain	NULL
reaction	NULL
products	NULL
subcloned	NULL
into	NULL
pQE30	NULL
to	NULL
generate	NULL
the	NULL
NFATe.8	NULL
(	NULL
amino	NULL
acids	NULL
214-814	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
expression	NULL
vector	NULL
.	NULL

The	NULL
other	NULL
two	NULL
deletion	NULL
mutants	NULL
,	NULL
NFATe.6	NULL
(	NULL
amino	NULL
acids	NULL
214-769	NULL
)	NULL
and	NULL
NFATe.6	NULL
(	NULL
amino	NULL
acids	NULL
214-703	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
were	NULL
derived	NULL
from	NULL
the	NULL
NFATe.8	NULL
(	NULL
214-814	NULL
)	NULL
expression	NULL
plasmid	NULL
by	NULL
blunt	NULL
end	NULL
ligation	NULL
of	NULL
the	NULL
plasmid	NULL
after	NULL
restriction	NULL
digestion	NULL
with	NULL
either	NULL
Smal	NULL
and	NULL
EcoRV	NULL
or	NULL
Agel	NULL
and	NULL
EcoRV	NULL
,	NULL
respectively	NULL
.	NULL

Murine	NULL
NFATp	NULL
expression	NULL
vector	NULL
pNFATpXS	NULL
(	NULL
I-297	NULL
)	NULL
,	NULL
constructed	NULL
in	NULL
pQE31	NULL
(	NULL
Qaigen	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Drs	NULL
.	NULL

A.	NULL
Rao	NULL
and	NULL
J.	NULL
Jain	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Proteins	NULL
were	NULL
expressed	NULL
and	NULL
purified	NULL
as	NULL
described	NULL
previously	NULL
with	NULL
minor	NULL
modifications	NULL
(	NULL
86	NULL
)	NULL
.	NULL

Expression	NULL
was	NULL
induced	NULL
by	NULL
addition	NULL
of	NULL
2	NULL
mM	NULL
isopropyl-B-D-thiogalactopyranoside	NULL
to	NULL
K.	NULL
coli	NULL
culture	NULL
at	NULL
ODs	NULL
,	NULL
,	NULL
0.7-0.9	NULL
,	NULL
and	NULL
the	NULL
cultures	NULL
were	NULL
harvested	NULL
after	NULL
4	NULL
h	NULL
incubation	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
disrupted	NULL
by	NULL
three	NULL
cycles	NULL
of	NULL
freeze-thawing	NULL
in	NULL
8	NULL
M	NULL
urea	NULL
,	NULL
5	NULL
mM	NULL
*	NULL
To	NULL
distinguish	NULL
NFATe	NULL
isoforms	NULL
,	NULL
we	NULL
have	NULL
used	NULL
an	NULL
arbitrary	NULL
nomenclature	NULL
in	NULL
which	NULL
NFATe	NULL
previously	NULL
reported	NULL
by	NULL
Northrop	NULL
ef	NULL
al	NULL
.	NULL

(	NULL
21	NULL
)	NULL
is	NULL
referred	NULL
to	NULL
as	NULL
NFATe	NULL
.	NULL

«	NULL
.	NULL

20915	NULL
2-mercaptoethanol	NULL
,	NULL
0.1	NULL
M	NULL
sodium	NULL
phosphate	NULL
,	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.0	NULL
.	NULL

The	NULL
lysates	NULL
were	NULL
spun	NULL
in	NULL
microcentrifuge	NULL
for	NULL
10	NULL
min	NULL
to	NULL
remove	NULL
insoluble	NULL
particulates	NULL
.	NULL

Proteins	NULL
were	NULL
purified	NULL
from	NULL
the	NULL
soluble	NULL
fractions	NULL
of	NULL
the	NULL
extracts	NULL
with	NULL
nickel-chelate	NULL
resin	NULL
(	NULL
Ni-NTA-agarose	NULL
;	NULL
Qaigen	NULL
)	NULL
.	NULL

After	NULL
washing	NULL
the	NULL
resin	NULL
column	NULL
with	NULL
10	NULL
mM	NULL
imidazole	NULL
in	NULL
the	NULL
same	NULL
buffer	NULL
,	NULL
proteins	NULL
were	NULL
eluted	NULL
with	NULL
100	NULL
mM	NULL
imidazole	NULL
.	NULL

The	NULL
eluates	NULL
were	NULL
dialyzed	NULL
against	NULL
a	NULL
buffer	NULL
(	NULL
20	NULL
mm	NULL
HEPES	NULL
pH	NULL
7.4	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
100	NULL
mM	NULL
KCI	NULL
,	NULL
0.5	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylsulfony	NULL
]	NULL
fluoride	NULL
)	NULL
containing	NULL
4	NULL
M	NULL
urea	NULL
for	NULL
6	NULL
h	NULL
,	NULL
and	NULL
overnight	NULL
against	NULL
an	NULL
urea-free	NULL
dialysis	NULL
buffer	NULL
.	NULL

Proteins	NULL
were	NULL
stored	NULL
in	NULL
small	NULL
aliquots	NULL
at	NULL
-70	NULL
°C	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
determined	NULL
using	NULL
the	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
kit	NULL
with	NULL
bovine	NULL
serum	NULL
albumin	NULL
as	NULL
standard	NULL
.	NULL

To	NULL
verify	NULL
the	NULL
purification	NULL
,	NULL
0.2	NULL
pg	NULL
of	NULL
each	NULL
purified	NULL
protein	NULL
was	NULL
separated	NULL
in	NULL
SDS-PAGE	NULL
and	NULL
stained	NULL
with	NULL
Coomassie	NULL
Brilliant	NULL
Blue	NULL
.	NULL

Purified	NULL
recombinant	NULL
e-Fos	NULL
(	NULL
1-321	NULL
)	NULL
and	NULL
c-Jun	NULL
(	NULL
199-834	NULL
)	NULL
proteins	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Drs	NULL
.	NULL

T.	NULL
Curran	NULL
and	NULL
T.	NULL
Kerppola	NULL
and	NULL
have	NULL
been	NULL
described	NULL
elsewhere	NULL
(	NULL
87	NULL
)	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay-Binding	NULL
reactions	NULL
(	NULL
16	NULL
pul	NULL
)	NULL
were	NULL
performed	NULL
with	NULL
0.16	NULL
ng	NULL
to	NULL
0.3	NULL
pg	NULL
of	NULL
purified	NULL
NFATe.f	NULL
and	NULL
NFATp	NULL
proteins	NULL
,	NULL
300	NULL
ng	NULL
of	NULL
poly	NULL
(	NULL
dl	NULL
)	NULL
poly	NULL
(	NULL
dC	NULL
)	NULL
,	NULL
and	NULL
0.2-0.3	NULL
ng	NULL
of	NULL
radiolabeled	NULL
oligonucleotides	NULL
in	NULL
a	NULL
binding	NULL
buffer	NULL
containing	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
0.5	NULL
mx	NULL
dithiothreitol	NULL
,	NULL
1	NULL
%	NULL
Ficoll	NULL
(	NULL
M	NULL
,	NULL
400,000	NULL
)	NULL
,	NULL
0.125	NULL
mg/ml	NULL
bovine	NULL
serum	NULL
albumin	NULL
.	NULL

For	NULL
competition	NULL
assays	NULL
,	NULL
25-100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotides	NULL
were	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
mixtures	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
proteins	NULL
were	NULL
included	NULL
in	NULL
the	NULL
binding	NULL
reaction	NULL
mixtures	NULL
to	NULL
test	NULL
their	NULL
association	NULL
with	NULL
NFAT	NULL
proteins	NULL
.	NULL

After	NULL
20-min	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
the	NULL
reaction	NULL
products	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
4	NULL
%	NULL
non-denaturing	NULL
polyacrylamide	NULL
gel	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
used	NULL
in	NULL
DNA	NULL
binding	NULL
assays	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
1	NULL
)	NULL
human	NULL
NFAT	NULL
,	NULL
a	NULL
30-mer	NULL
containing	NULL
the	NULL
distal	NULL
NFAT	NULL
site	NULL
within	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
(	NULL
5'-GGAGGAAAAACTGTTTCATACAGAAG-GCGT-3	NULL
'	NULL
)	NULL
;	NULL
2	NULL
)	NULL
murine	NULL
NFAT	NULL
,	NULL
a	NULL
33-mer	NULL
containing	NULL
the	NULL
distal	NULL
NFAT	NULL
site	NULL
in	NULL
the	NULL
murine	NULL
IL-2	NULL
promoter	NULL
(	NULL
5'-gatecGCCCAAAGAGGAAAATTTGTT-TCATACAG-3	NULL
'	NULL
)	NULL
;	NULL
3	NULL
)	NULL
mutant	NULL
NFAT	NULL
,	NULL
a	NULL
30-mer	NULL
containing	NULL
5	NULL
base	NULL
changes	NULL
at	NULL
the	NULL
5'-end	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
NFAT	NULL
site	NULL
(	NULL
5'-CGTCCTAAAACTGTT-TCATACAGAAGGCGT	NULL
3	NULL
``	NULL
)	NULL
;	NULL
4	NULL
)	NULL
nonspecific	NULL
oligonucleotide	NULL
,	NULL
a	NULL
33-mer	NULL
(	NULL
5	NULL
'	NULL
AAGAAGGAGAAAATACCTTTTTGATTTTCACA	NULL
3	NULL
'	NULL
)	NULL
;	NULL
5	NULL
)	NULL
AP-1	NULL
,	NULL
a	NULL
24-mer	NULL
containing	NULL
the	NULL
AP-1	NULL
binding	NULL
site	NULL
(	NULL
5'-CGCTTGATGAGTCAGCCGGAA-3	NULL
'	NULL
)	NULL
;	NULL
6	NULL
)	NULL
x3	NULL
element	NULL
,	NULL
a	NULL
30-mer	NULL
containing	NULL
the	NULL
NFAT-binding	NULL
site	NULL
within	NULL
the	NULL
human	NULL
TNF-	NULL
«	NULL
promoter	NULL
(	NULL
5'-gatecGAGCTCATGGGTTTCTCCAC-CAAGG-3	NULL
'	NULL
)	NULL
(	NULL
35	NULL
)	NULL
.	NULL

DNA	NULL
Transfections-The	NULL
full-length	NULL
coding	NULL
region	NULL
of	NULL
NFATec.f	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
expression	NULL
vector	NULL
containing	NULL
the	NULL
SRa	NULL
promoter	NULL
(	NULL
88	NULL
)	NULL
.	NULL

The	NULL
NFATp	NULL
expression	NULL
vector	NULL
,	NULL
in	NULL
which	NULL
NFAT	NULL
p	NULL
expression	NULL
is	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
SV40	NULL
promoter	NULL
,	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Drs	NULL
.	NULL

A.	NULL
Rao	NULL
and	NULL
P.	NULL
Hogan	NULL
(	NULL
Harvard	NULL
Medical	NULL
School	NULL
)	NULL
.	NULL

The	NULL
reporter	NULL
plasmid	NULL
5B3.1	NULL
,	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
Dr.	NULL
G.	NULL
Crabtree	NULL
(	NULL
Stanford	NULL
University	NULL
)	NULL
,	NULL
expresses	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
driven	NULL
by	NULL
three	NULL
IL-2	NULL
NFAT	NULL
sites	NULL
upstream	NULL
of	NULL
a	NULL
minimal	NULL
y-fibrinogen	NULL
promoter	NULL
(	NULL
39	NULL
)	NULL
.	NULL

The	NULL
human	NULL
TNF-	NULL
«	NULL
promoter	NULL
(	NULL
-614/+20	NULL
)	NULL
-luciferase	NULL
plasmid	NULL
constructed	NULL
in	NULL
pGL2	NULL
basic	NULL
vector	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
F.	NULL
de	NULL
la	NULL
Brousse	NULL
,	NULL
Tularik	NULL
,	NULL
Inc.	NULL
(	NULL
40	NULL
)	NULL
.	NULL

The	NULL
pTKGH	NULL
plasmid	NULL
which	NULL
expresses	NULL
human	NULL
growth	NULL
hormone	NULL
(	NULL
hGH	NULL
)	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
serves	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
for	NULL
the	NULL
efficiency	NULL
of	NULL
transfection	NULL
.	NULL

Exponentially	NULL
growing	NULL
Jurkat	NULL
or	NULL
Raji	NULL
cells	NULL
(	NULL
1	NULL
%	NULL
10	NULL
``	NULL
cells	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
5B3.1	NULL
or	NULL
the	NULL
TNF-	NULL
«	NULL
promoter-luciferase	NULL
plasmid	NULL
,	NULL
2.5	NULL
pg	NULL
of	NULL
pTKGH	NULL
,	NULL
and	NULL
15	NULL
pg	NULL
of	NULL
either	NULL
or	NULL
NFATp	NULL
expression	NULL
vector	NULL
by	NULL
electroporation	NULL
at	NULL
240	NULL
V	NULL
,	NULL
960	NULL
microfarads	NULL
.	NULL

At	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
50	NULL
ng/ml	NULL
PMA	NULL
and	NULL
1.5	NULL
um	NULL
ionomycin	NULL
.	NULL

After	NULL
8	NULL
h	NULL
of	NULL
treatment	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
and	NULL
CAT	NULL
and	NULL
luciferase	NULL
activities	NULL
were	NULL
determined	NULL
using	NULL
the	NULL
established	NULL
techniques	NULL
.	NULL

Transfection	NULL
efficiencies	NULL
were	NULL
normalized	NULL
by	NULL
hGH	NULL
assays	NULL
using	NULL
Allegro	NULL
HGH	NULL
kit	NULL
(	NULL
Nichols	NULL
Institute	NULL
Diagnostics	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

RESULTS	NULL
Cloning	NULL
of	NULL
NFATe.B-To	NULL
isolate	NULL
a	NULL
cDNA	NULL
clone	NULL
(	NULL
s	NULL
)	NULL
which	NULL
pu	NULL
tatively	NULL
encodes	NULL
an	NULL
NFAT	NULL
family	NULL
protein	NULL
from	NULL
B	NULL
cells	NULL
,	NULL
we	NULL
screened	NULL
a	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
line	NULL
Raji	NULL
cDNA	NULL
library	NULL
(	NULL
approximately	NULL
7	NULL
X	NULL
10°	NULL
plaques	NULL
)	NULL
with	NULL
a	NULL
cDNA	NULL
probe	NULL
encoding	NULL
and	NULL
the	NULL
rel	NULL
similarity	NULL
domain	NULL
of	NULL
the	NULL
murine	NULL
NFATp	NULL
at	NULL
low	NULL
stringency	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Several	NULL
positive	NULL
clones	NULL
were	NULL
isolated	NULL
and	NULL
divided	NULL
into	NULL
two	NULL
different	NULL
groups	NULL
closely	NULL
related	NULL
to	NULL
NFATe	NULL
.	NULL

«	NULL
(	NULL
5	NULL
clones	NULL
)	NULL
and	NULL
NFATp	NULL
(	NULL
10	NULL
clones	NULL
)	NULL
,	NULL
respectively	NULL
,	NULL
by	NULL
initial	NULL
analysis	NULL
using	NULL
restriction	NULL
digestion	NULL
and	NULL
partial	NULL
sequenc-ing	NULL
.	NULL

Interestingly	NULL
,	NULL
one	NULL
clone	NULL
related	NULL
to	NULL
the	NULL
NFATc	NULL
.	NULL

«	NULL
gene	NULL
showed	NULL
nucleotide	NULL
sequence	NULL
differences	NULL
in	NULL
both	NULL
5'-	NULL
and	NULL
3'-end	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
20916	NULL
130	NULL
259	NULL
388	NULL
517	NULL
646	NULL
775	NULL
904	NULL
1033	NULL
1162	NULL
1291	NULL
1420	NULL
1549	NULL
1678	NULL
1807	NULL
1936	NULL
2065	NULL
2194	NULL
2323	NULL
2452	NULL
2581	NULL
2710	NULL
Transcription	NULL
Factor	NULL
NFAT	NULL
Gene	NULL
Family	NULL
gaat	NULL
MOT	NULL
G	NULL
L	NULL
E	NULL
D	NULL
Q	NULL
E	NULL
F	NULL
D	NULL
F	NULL
E	NULL
P	NULL
FOE	NULL
F	NULL
N	NULL
CAGCGCGACGAGGGCGCCGCCECGECCGCCCCAGAACACTATGGCTATGCATCCTCCAACGTCAGCCCCGCCCTGCCECTCCCCACGECGCACTCCACCCTECCGECCCCETECCACAACCTTCACACC	NULL
Q	NULL
R	NULL
D	NULL
B	NULL
G	NULL
A	NULL
A	NULL
A	NULL
A	NULL
A	NULL
B	NULL
OR	NULL
H	NULL
Y	NULL
G	NULL
¥	NULL
A	NULL
S	NULL
S	NULL
N	NULL
V	NULL
S	NULL
P	NULL
A	NULL
L	NULL
P	NULL
L	NULL
P	NULL
oT	NULL
A	NULL
H	NULL
S	NULL
T	NULL
L	NULL
P	NULL
A	NULL
PoC	NULL
H	NULL
N	NULL
L	NULL
Q	NULL
T	NULL
TCCACACCGGGCATCATCCCGCCGGCGGATCACCCCTCGGGGTACGGAGCAGCTTTGGACGGTGGGCCTGCGGGCTACTTCCTCTCCTCCGGCCACACCAGGCCTGATGGGGCCCCTGCCCTGGAGAGT	NULL
§	NULL
T	NULL
BP	NULL
G	NULL
I	NULL
I	NULL
P	NULL
P	NULL
A	NULL
D	NULL
H	NULL
B	NULL
S	NULL
G	NULL
Y	NULL
G	NULL
A	NULL
A	NULL
L	NULL
D	NULL
G	NULL
G	NULL
P	NULL
A	NULL
G	NULL
S	NULL
CCTCGCATCGAGATAACCTCGTGCTTGGGCCTGTACCACAACAATAACCAGTTTTTCCACGATGTGGAGGTGGAAGACGTCCTCCCTAGCTCCAAACGGTCCCCCTCCACGGCCACGCTGAGTCTGCCC	NULL
POR	NULL
I	NULL
R	NULL
I	NULL
T	NULL
S	NULL
G	NULL
L	NULL
vy	NULL
H	NULL
N	NULL
N	NULL
N	NULL
For	NULL
HD	NULL
V	NULL
B	NULL
v	NULL
E	NULL
D	NULL
V	NULL
L	NULL
P	NULL
S	NULL
S	NULL
K	NULL
R	NULL
S	NULL
Pos	NULL
T	NULL
A	NULL
T	NULL
$	NULL
L	NULL
P	NULL
AGCCTGGAGGCCTACACAGACCCCTCETGCCTEAGCCCEGCCAGCAGCCTETCCTCCCGEGAGCTECAACTCAGAGGCCTCCTCCTACGASTCCAACTACTCGTACCCGTACGCETCCCCCCAGACGTCG	NULL
§	NULL
L	NULL
E	NULL
A	NULL
Y	NULL
R	NULL
D	NULL
P	NULL
S	NULL
C	NULL
L	NULL
§	NULL
B	NULL
A	NULL
S	NULL
S	NULL
L	NULL
S	NULL
§	NULL
R	NULL
S	NULL
C	NULL
N	NULL
S	NULL
R	NULL
A	NULL
S	NULL
Ss	NULL
¥	NULL
E	NULL
s	NULL
N	NULL
Y	NULL
S	NULL
Y	NULL
P	NULL
Y	NULL
A	NULL
P	NULL
CCATGGCAGTCTCCCTGCGTGTCTCCCAAGACCACGGACCCCGAGCAGGGCTTTCCCCECGEGCTGGGGECCTECACACTGCTGAGTTCCCCGCGSCACTCCCCCTCCACCTCeCCCCececcacceTe	NULL
P	NULL
_	NULL
0	NULL
P	NULL
_C	NULL
Y	NULL
S	NULL
ROK	NULL
T	NULL
T	NULL
D	NULL
BP	NULL
BOE	NULL
G	NULL
F	NULL
P	NULL
R	NULL
G	NULL
L	NULL
G	NULL
A	NULL
C	NULL
T	NULL
L	NULL
L	NULL
S	NULL
P	NULL
ROH	NULL
S	NULL
P	NULL
S	NULL
TO	NULL
S	NULL
POR	NULL
A	NULL
S	NULL
v	NULL
ACTGAGGAGAGCTGGCTGGGTGCCCGCTCCTCCAGACCCGCGTCCCCTTGCAACAAGAGGAAGTACAGCCTCAACGGCCGGCAGCCGCCCTACTCACCCCACCACTCGCCCACGCCATCCCCGCACGGC	NULL
_T	NULL
BE	NULL
W	NULL
L	NULL
G	NULL
A	NULL
R	NULL
S	NULL
S	NULL
R	NULL
B	NULL
A	NULL
S	NULL
P	NULL
C	NULL
N	NULL
K	NULL
R	NULL
OK	NULL
Y	NULL
S	NULL
L	NULL
N	NULL
G	NULL
R	NULL
Q	NULL
P	NULL
P	NULL
Y	NULL
S	NULL
P	NULL
SP	NULL
P	NULL
_	NULL
S	NULL
P	NULL
TCCCCGCGGGTCAGCGTGACCGACGACTCGTGGTTGGGCAACACCACCCAGTACACCAGCTCGGCCATCGTGGCCGCCATCAACGCGCTGACCACCGACAGCAGCCTGGACCTGGGAGATGGCGTCCCT	NULL
§	NULL
P	NULL
ROV	NULL
S	NULL
V	NULL
T	NULL
D	NULL
D	NULL
Ss	NULL
WoL	NULL
G	NULL
N	NULL
T	NULL
T	NULL
Q	NULL
¥	NULL
T	NULL
s	NULL
S	NULL
A	NULL
I	NULL
V	NULL
A	NULL
A	NULL
I	NULL
N	NULL
A	NULL
L	NULL
T	NULL
T	NULL
§	NULL
L	NULL
D	NULL
L	NULL
G	NULL
D	NULL
G	NULL
V	NULL
P	NULL
GTCAAGTCCCGCAAGACCACCCTGGAGCAGCCGCCCTCAGTEGCECTCAAGGTGEGAGCCCETCEGGCAGGACCTGGECAGCCCCCCGCCCCCEGCCGACTTCECECCCGAAGACTACTCCTCTTTCCAG	NULL
V	NULL
K	NULL
Ss	NULL
ROK	NULL
T	NULL
T	NULL
L	NULL
E	NULL
Q	NULL
P	NULL
P	NULL
S	NULL
V	NULL
A	NULL
LOK	NULL
V	NULL
E	NULL
P	NULL
V	NULL
G	NULL
E	NULL
D	NULL
L	NULL
G	NULL
S	NULL
P	NULL
P	NULL
P	NULL
A	NULL
D	NULL
F	NULL
A	NULL
POE	NULL
D	NULL
Y	NULL
S	NULL
s	NULL
F	NULL
Q	NULL
CACATCAGGAAGGGCGGCTTCTGCGACCAGTACCTEGCGETGCCGCAGCACCCCTACCAGTGGGCGAAGCCCAAGCCCCTGTCCCCTACGTCCTACATGAGCCCCACCCTGCCCGCCCTEGACTEGCAG	NULL
H0	NULL
I	NULL
R	NULL
K	NULL
G	NULL
G	NULL
F	NULL
C	NULL
D	NULL
Q	NULL
Y	NULL
L	NULL
A	NULL
v	NULL
P	NULL
Q	NULL
HOP	NULL
Y	NULL
A	NULL
K	NULL
BoK	NULL
POL	NULL
T	NULL
S	NULL
Y	NULL
M	NULL
s	NULL
BoT	NULL
L	NULL
P	NULL
A	NULL
L	NULL
D	NULL
W	NULL
Q	NULL
L	NULL
P	NULL
S	NULL
H	NULL
S	NULL
G	NULL
BOY	NULL
R	NULL
L	NULL
R	NULL
I	NULL
E	NULL
V	NULL
q	NULL
P	NULL
K	NULL
S	NULL
HOH	NULL
R	NULL
A	NULL
E	NULL
G	NULL
S	NULL
R	NULL
G	NULL
A	NULL
v	NULL
K	NULL
A	NULL
Ss	NULL
A	NULL
G	NULL
G	NULL
H	NULL
P	NULL
I	NULL
v	NULL
CAGCTGCATGGCTACTTGGACAATGAGCCGCTGATGCTGCAGCTTTTCATIGGGACGECGCACGACCECCTGCTGCGCCCGCACGCCTTCTACCAGETECACCECATCACAGCCAACACCGTETCCACC	NULL
Q	NULL
L	NULL
H	NULL
G	NULL
Y	NULL
L	NULL
E	NULL
N	NULL
E	NULL
POL	NULL
M	NULL
L	NULL
Q	NULL
L	NULL
F	NULL
I	NULL
G	NULL
T	NULL
A	NULL
D	NULL
D	NULL
R	NULL
L	NULL
L	NULL
R	NULL
B	NULL
H	NULL
A	NULL
F	NULL
oY	NULL
Q	NULL
V	NULL
H	NULL
R	NULL
I	NULL
T	NULL
G	NULL
K	NULL
T	NULL
v	NULL
Ss	NULL
T	NULL
ACCAGCCACGAGGCCATCCTCTCCAACACCAAAGTCCTGCAGATCCCACTCCTGCCGEAGAACAGCATGCGAGCCGTCATTGACTGTGCCGGAATCCTCAAACTCAGAAACTCCCACATTGAACTTCGG	NULL
T	NULL
S	NULL
HOE	NULL
A	NULL
I	NULL
L	NULL
S	NULL
N	NULL
T	NULL
K	NULL
V	NULL
L	NULL
E	NULL
I	NULL
B	NULL
L	NULL
L	NULL
PBE	NULL
N	NULL
S	NULL
M	NULL
R	NULL
A	NULL
V	NULL
I	NULL
D	NULL
C	NULL
A	NULL
G	NULL
I	NULL
L	NULL
K	NULL
L	NULL
R	NULL
N	NULL
S	NULL
D	NULL
E	NULL
L	NULL
R	NULL
AAAGGAGAGACGGACATCGGGAGGAAGAACACACGGGTACGGCTGGTGTTCCGCGTTCACGTCCCGCAACCCAGCGGCCGCACGCTGTCCCTGCAGGTGGCCTCCAACCCCATCGAATGCTCCCAGCGC	NULL
X	NULL
G	NULL
R	NULL
T	NULL
D	NULL
I	NULL
G	NULL
R	NULL
K	NULL
N	NULL
T	NULL
R	NULL
V	NULL
R	NULL
v	NULL
OF	NULL
R	NULL
V	NULL
H	NULL
V	NULL
P	NULL
Q	NULL
P	NULL
G	NULL
R	NULL
T	NULL
L	NULL
v	NULL
A	NULL
Ss	NULL
N	NULL
P	NULL
I	NULL
E	NULL
CoS	NULL
TCAGCTCAGGAGCTGCCTCTGGTGGAGAAGCAGAGCACGGACAGCTATCCGGTCGTGGGCGGGAAGAAGATGGTCCTGTCTGGCCACAACTTCCTGCAGGACTCCAAGGTCATTTTCGTGGAGAAAGCC	NULL
§	NULL
A	NULL
Q	NULL
E	NULL
L	NULL
BOL	NULL
V	NULL
R	NULL
K	NULL
Q	NULL
s	NULL
T	NULL
D	NULL
§	NULL
¥	NULL
B	NULL
ov	NULL
v	NULL
G	NULL
G	NULL
K	NULL
K	NULL
M	NULL
V	NULL
§	NULL
G	NULL
H	NULL
N	NULL
F	NULL
L	NULL
Q	NULL
D	NULL
§	NULL
K	NULL
V	NULL
I	NULL
F	NULL
V	NULL
E	NULL
K	NULL
A	NULL
CCAGATGGCCACCATGTCTGGGAGATGGAAGCGAAAACTCACCGGGACCTETECAAGCCCAATTCTCTEGTGGTTGAGATCCCGCCGTTTCGGAATCAGAGGATAACCAGCCCCETTCACETCAGTTTC	NULL
P	NULL
D	NULL
G	NULL
H	NULL
H	NULL
V	NULL
W	NULL
BR	NULL
M	NULL
R	NULL
A	NULL
K	NULL
T	NULL
D	NULL
R	NULL
D	NULL
L	NULL
C	NULL
K	NULL
B	NULL
N	NULL
S	NULL
L	NULL
V	NULL
V	NULL
E	NULL
I	NULL
B	NULL
P	NULL
F	NULL
R	NULL
N	NULL
Q	NULL
R	NULL
I	NULL
T	NULL
Ss	NULL
PoV	NULL
H	NULL
V	NULL
Sor	NULL
TACGTCTGCAACGGGAACACAAAGCGAAGCCAGTACCAGCGTTTCACCTACCTTCCCECCAACGTTCCAATTATAAAAACAGAACCCACTGATGATTATGAGCCTGCTCCAACCTGTGGACCGGTGAGC	NULL
¥	NULL
v	NULL
C	NULL
N	NULL
G	NULL
K	NULL
R	NULL
K	NULL
R	NULL
S	NULL
YQ	NULL
ROF	NULL
OT	NULL
Y	NULL
LOP	NULL
,	NULL
A	NULL
N	NULL
V	NULL
BOI	NULL
I	NULL
K	NULL
T	NULL
B	NULL
POT	NULL
D	NULL
D	NULL
Y	NULL
E	NULL
B	NULL
A	NULL
BoT	NULL
C	NULL
G	NULL
PoV	NULL
S	NULL
CAGGGCTTAAGTCCTCTCCCAAGACCATACTACAGCCAGCAGCTCGCGATGCCACCCGACCCCAGCTCCTGCCTCGTEGCCESCTTCCCECCCTGTCCECAGAGCAACCACCCTGATECCAGCGGCCCCT	NULL
Q	NULL
G	NULL
L	NULL
Ss	NULL
POL	NULL
POR	NULL
Boy	NULL
Yos	NULL
A	NULL
M	NULL
P	NULL
P	NULL
D	NULL
L	NULL
V	NULL
A	NULL
G	NULL
F	NULL
B	NULL
P	NULL
C	NULL
P	NULL
Q	NULL
R	NULL
S	NULL
T	NULL
L	NULL
M	NULL
B	NULL
A	NULL
A	NULL
P	NULL
GGCGTGAGCCCAAGCTCCACGACCTTTCTCCCGCTGCCTACACCAAGGGCGTTGCCAGCCCGGGCCACTETCACCTCGGACTCCCGCAGCCGGCCECACAGECCCCCECCETCCAGGACGTEeCCCAGCC	NULL
G	NULL
vy	NULL
s	NULL
BP	NULL
s	NULL
§	NULL
T	NULL
T	NULL
R	NULL
OL	NULL
BOL	NULL
BOT	NULL
P	NULL
A	NULL
L	NULL
BPA	NULL
R	NULL
A	NULL
To	NULL
V	NULL
T	NULL
S	NULL
D	NULL
S	NULL
ROS	NULL
R	NULL
P	NULL
E	NULL
R	NULL
P	NULL
§	NULL
R	NULL
T	NULL
C	NULL
P	NULL
A	NULL
AGTGGCCACGCACCCCGeCTCecCCesecasccaceeccescCCTecTGCCAaCAGCACTAAATGAAATAATACGAAATGACCTICTCCAGCACGAGCACCCACTCCtagttgccacattggagcactcag	NULL
§	NULL
G	NULL
H	NULL
A	NULL
POR	NULL
L	NULL
A	NULL
R	NULL
A	NULL
A	NULL
T	NULL
P	NULL
G	NULL
BoA	NULL
A	NULL
T	NULL
A	NULL
V	NULL
N	NULL
BE	NULL
I	NULL
I	NULL
R	NULL
N	NULL
D	NULL
L	NULL
S	NULL
T	NULL
Ss	NULL
T	NULL
H	NULL
s	NULL
*	NULL
ttcagcaggggtatgctgacttcagcagacaaagacttttgaatamataaactgaactcacacctggtaccactcagaacctccaactgactgaatgccaggagctgaacattaatatgtgcaaagatt	NULL
te	NULL
2839	NULL
atgggaacggcccacacgcagtttgaceccacgcocagcocttctggcaccoectggggttcaatactggaagtgecttatttaaccagaccatca	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Nucleotide	NULL
and	NULL
deduced	NULL
amino	NULL
acid	NULL
sequences	NULL
of	NULL
human	NULL
6	NULL
.	NULL

Nucleotide	NULL
sequences	NULL
are	NULL
numbered	NULL
on	NULL
the	NULL
Zeft	NULL
,	NULL
and	NULL
amino	NULL
acid	NULL
residues	NULL
are	NULL
numbered	NULL
on	NULL
the	NULL
right	NULL
.	NULL

Three	NULL
SP	NULL
repeat	NULL
motifs	NULL
are	NULL
underlined	NULL
,	NULL
and	NULL
the	NULL
amino	NULL
acid	NULL
sequence	NULL
flanked	NULL
by	NULL
arrows	NULL
represents	NULL
the	NULL
rel	NULL
similarity	NULL
region	NULL
.	NULL

A	NULL
star	NULL
denotes	NULL
a	NULL
stop	NULL
codon	NULL
.	NULL

regions	NULL
,	NULL
and	NULL
further	NULL
sequencing	NULL
analysis	NULL
of	NULL
this	NULL
clone	NULL
,	NULL
designated	NULL
revealed	NULL
an	NULL
open	NULL
reading	NULL
frame	NULL
encoding	NULL
a	NULL
new	NULL
protein	NULL
of	NULL
827	NULL
amino	NULL
acids	NULL
with	NULL
deduced	NULL
molecular	NULL
mass	NULL
of	NULL
89.5	NULL
kDa	NULL
that	NULL
is	NULL
closely	NULL
related	NULL
to	NULL
NFAT	NULL
'	NULL
c.	NULL
«	NULL
previously	NULL
reported	NULL
by	NULL
Northrop	NULL
et	NULL
al	NULL
.	NULL

(	NULL
19	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

At	NULL
the	NULL
amino	NULL
acid	NULL
level	NULL
,	NULL
this	NULL
clone	NULL
displayed	NULL
perfect	NULL
sequence	NULL
identity	NULL
with	NULL
NFAT	NULL
'	NULL
c.	NULL
«	NULL
in	NULL
the	NULL
region	NULL
corresponding	NULL
to	NULL
amino	NULL
acids	NULL
30-684	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
2	NULL
amino	NULL
acids	NULL
at	NULL
positions	NULL
219	NULL
(	NULL
Ser	NULL
)	NULL
and	NULL
222	NULL
(	NULL
Arg	NULL
)	NULL
in	NULL
which	NULL
the	NULL
corresponding	NULL
amino	NULL
acids	NULL
of	NULL
NFATc	NULL
.	NULL

«	NULL
are	NULL
Gly	NULL
and	NULL
Gln	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
identical	NULL
region	NULL
includes	NULL
the	NULL
rel	NULL
similarity	NULL
domain	NULL
and	NULL
NH-terminal	NULL
containing	NULL
the	NULL
SPXXSPXX-SPXXXXX	NULL
(	NULL
D/E	NULL
)	NULL
(	NULL
D/E	NULL
)	NULL
repeat	NULL
motifs	NULL
that	NULL
are	NULL
well	NULL
conserved	NULL
in	NULL
the	NULL
NFAT	NULL
family	NULL
proteins	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
new	NULL
NFAT	NULL
family	NULL
protein	NULL
may	NULL
play	NULL
a	NULL
similar	NULL
biological	NULL
role	NULL
as	NULL
other	NULL
NFAT	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
two	NULL
unique	NULL
regions	NULL
were	NULL
found	NULL
in	NULL
NFATe.f	NULL
.	NULL

The	NULL
first	NULL
NH-terminal	NULL
29	NULL
amino	NULL
acids	NULL
of	NULL
differ	NULL
from	NULL
that	NULL
of	NULL
NFATc	NULL
.	NULL

«	NULL
and	NULL
are	NULL
rich	NULL
in	NULL
acidic	NULL
amino	NULL
acid	NULL
content	NULL
(	NULL
8	NULL
of	NULL
29	NULL
amino	NULL
acids	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
region	NULL
may	NULL
constitute	NULL
a	NULL
transactivation	NULL
domain	NULL
.	NULL

Another	NULL
unique	NULL
region	NULL
of	NULL
NFATe	NULL
.	NULL

$	NULL
is	NULL
represented	NULL
by	NULL
an	NULL
additional	NULL
sequence	NULL
of	NULL
142	NULL
amino	NULL
acids	NULL
at	NULL
the	NULL
COOH	NULL
terminus	NULL
,	NULL
and	NULL
this	NULL
region	NULL
,	NULL
rich	NULL
in	NULL
proline	NULL
residues	NULL
(	NULL
~20	NULL
%	NULL
)	NULL
,	NULL
shows	NULL
no	NULL
significant	NULL
sequence	NULL
similarity	NULL
to	NULL
the	NULL
corresponding	NULL
regions	NULL
of	NULL
other	NULL
NFAT	NULL
family	NULL
members	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
cDNA	NULL
clone	NULL
isolated	NULL
here	NULL
appears	NULL
to	NULL
encode	NULL
a	NULL
new	NULL
isoform	NULL
of	NULL
NFAT	NULL
'	NULL
c.	NULL
«	NULL
that	NULL
most	NULL
likely	NULL
resulted	NULL
from	NULL
alternative	NULL
splicing	NULL
and/or	NULL
transcription	NULL
from	NULL
separate	NULL
promoters	NULL
.	NULL

Expression	NULL
Pattern	NULL
of	NULL
NFATc.B	NULL
mRNA	NULL
in	NULL
Human	NULL
Tissues-Previous	NULL
reports	NULL
have	NULL
shown	NULL
that	NULL
Northern	NULL
analysis	NULL
of	NULL
NFATc	NULL
using	NULL
5'-end	NULL
fragments	NULL
of	NULL
NFATe	NULL
cDNA	NULL
as	NULL
a	NULL
probe	NULL
displayed	NULL
two	NULL
hybridizing	NULL
bands	NULL
with	NULL
apparent	NULL
sizes	NULL
of	NULL
2.7	NULL
and	NULL
4.5	NULL
kb	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
the	NULL
new	NULL
clone	NULL
NFATc.f	NULL
can	NULL
be	NULL
specifically	NULL
assigned	NULL
to	NULL
one	NULL
of	NULL
these	NULL
two	NULL
bands	NULL
,	NULL
and	NULL
to	NULL
determine	NULL
the	NULL
tissue	NULL
distribution	NULL
of	NULL
NFATe.B	NULL
expression	NULL
,	NULL
we	NULL
carried	NULL
out	NULL
Northern	NULL
analysis	NULL
of	NULL
multiple	NULL
human	NULL
tissues	NULL
using	NULL
two	NULL
sepa-	NULL
rate	NULL
probes	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
when	NULL
a	NULL
common	NULL
sequence	NULL
of	NULL
NFAT	NULL
'	NULL
c.	NULL
«	NULL
and	NULL
NFATc.f	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
,	NULL
two	NULL
mRNA	NULL
species	NULL
with	NULL
previously	NULL
observed	NULL
sizes	NULL
were	NULL
detected	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
an	NULL
NFATe.B	NULL
unique	NULL
probe	NULL
corresponding	NULL
to	NULL
the	NULL
region	NULL
downstream	NULL
from	NULL
the	NULL
rel	NULL
similarity	NULL
domain	NULL
detected	NULL
only	NULL
the	NULL
4.5-kb	NULL
band	NULL
,	NULL
indicating	NULL
that	NULL
this	NULL
band	NULL
represents	NULL
NFATe.8	NULL
mRNA	NULL
.	NULL

The	NULL
2.7-kb	NULL
mRNA	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
appears	NULL
to	NULL
encode	NULL
NFATc	NULL
.	NULL

«	NULL
(	NULL
19	NULL
)	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
the	NULL
reported	NULL
cDNA	NULL
size	NULL
and	NULL
its	NULL
tissue	NULL
distribution	NULL
.	NULL

The	NULL
expression	NULL
pattern	NULL
of	NULL
these	NULL
two	NULL
mRNA	NULL
species	NULL
was	NULL
distinct	NULL
in	NULL
different	NULL
tissues	NULL
.	NULL

NFATc	NULL
.	NULL

«	NULL
mRNA	NULL
was	NULL
predominantly	NULL
expressed	NULL
in	NULL
the	NULL
thymus	NULL
and	NULL
peripheral	NULL
leukocytes	NULL
,	NULL
and	NULL
at	NULL
lower	NULL
levels	NULL
in	NULL
the	NULL
spleen	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
NFATe.8	NULL
mRNA	NULL
was	NULL
preferentially	NULL
expressed	NULL
in	NULL
the	NULL
spleen	NULL
and	NULL
at	NULL
lower	NULL
levels	NULL
in	NULL
all	NULL
other	NULL
tissues	NULL
tested	NULL
.	NULL

Interestingly	NULL
,	NULL
its	NULL
expression	NULL
level	NULL
was	NULL
higher	NULL
than	NULL
that	NULL
of	NULL
NFATec	NULL
.	NULL

«	NULL
in	NULL
all	NULL
tissues	NULL
except	NULL
the	NULL
thymus	NULL
and	NULL
peripheral	NULL
leukocytes	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
expression	NULL
of	NULL
these	NULL
two	NULL
isoforms	NULL
may	NULL
be	NULL
differentially	NULL
regulated	NULL
in	NULL
a	NULL
cell	NULL
type-specific	NULL
manner	NULL
.	NULL

Sequence-specific	NULL
DNA	NULL
Binding	NULL
of	NULL
NFAT	NULL
'	NULL
c	NULL
.	NULL

B	NULL
to	NULL
the	NULL
IL-2	NULL
NFAT	NULL
Site-To	NULL
characterize	NULL
biochemical	NULL
properties	NULL
of	NULL
NFATc.fB	NULL
,	NULL
we	NULL
generated	NULL
three	NULL
recombinant	NULL
derivatives	NULL
of	NULL
NFATc	NULL
.	NULL

$	NULL
that	NULL
were	NULL
tagged	NULL
with	NULL
a	NULL
hexahistidine	NULL
at	NULL
the	NULL
NH	NULL
,	NULL
terminus	NULL
.	NULL

NFATe.B	NULL
(	NULL
214-814	NULL
)	NULL
contains	NULL
601	NULL
amino	NULL
acids	NULL
corresponding	NULL
to	NULL
residues	NULL
214	NULL
to	NULL
814	NULL
which	NULL
include	NULL
the	NULL
rel	NULL
similarity	NULL
domain	NULL
(	NULL
~290	NULL
amino	NULL
acids	NULL
)	NULL
and	NULL
most	NULL
residues	NULL
at	NULL
the	NULL
COOH	NULL
terminus	NULL
of	NULL
NFATe.B	NULL
.	NULL

The	NULL
other	NULL
two	NULL
polypeptides	NULL
were	NULL
derived	NULL
from	NULL
NFATe.B	NULL
(	NULL
214-814	NULL
)	NULL
by	NULL
further	NULL
truncation	NULL
of	NULL
the	NULL
COOH	NULL
terminus	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
.	NULL

The	NULL
NFATc.6	NULL
(	NULL
214-703	NULL
)	NULL
polypeptide	NULL
is	NULL
devoid	NULL
of	NULL
most	NULL
COOH-terminal	NULL
residues	NULL
of	NULL
NFATc.B	NULL
,	NULL
and	NULL
thus	NULL
resembles	NULL
NFATc	NULL
.	NULL

«	NULL
.	NULL

A	NULL
deletion	NULL
derivative	NULL
of	NULL
NFATp	NULL
,	NULL
NFATpXS	NULL
(	NULL
1-297	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
rel	NULL
similarity	NULL
domain	NULL
of	NULL
NFATp	NULL
(	NULL
36	NULL
)	NULL
,	NULL
was	NULL
also	NULL
purified	NULL
and	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
in	NULL
DNA	NULL
binding	NULL
assays	NULL
.	NULL

The	NULL
deletion	NULL
proteins	NULL
were	NULL
expressed	NULL
in	NULL
E.	NULL
coli	NULL
and	NULL
purified	NULL
by	NULL
Ni-chelate	NULL
affinity	NULL
chromatography	NULL
.	NULL

The	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Transcription	NULL
Factor	NULL
NFAT	NULL
Gene	NULL
Family	NULL
A	NULL
NHz-terminus	NULL
i	NULL
(	NULL
29	NULL
)	NULL
NFATo	NULL
.	NULL

$	NULL
WTCLEDQEFDFEFLFEFNORDEGAAAAAP	NULL
/I———|	NULL
Rel	NULL
similariti	NULL
domain	NULL
|	NULL
Rel	NULL
domain	NULL
NFATc.q	NULL
-	NULL
MPSTSFPVPSKFPLGPAAAVF	NULL
GPAPRA	NULL
ARE	NULL
,	NULL
(	NULL
(	NULL
42	NULL
)	NULL
COOH-terminus	NULL
(	NULL
680	NULL
)	NULL
NFATc	NULL
.	NULL

$	NULL
Rel	NULL
similarity	NULL
domain	NULL
l—	NULL
PTTKTEPTDDYEPAPTCGPVSQGLSPLPRPYYSQOLAMPPDPSSCLVAGFPPCPQ	NULL
RSTLMPAAPGVSPSSTTFLPLPTPRALI	NULL
SRSRPERPPPSRTCPASCH	NULL
APRLARAATPGPAATAVNETIRNDLSSTSTHS	NULL
(	NULL
827	NULL
)	NULL
(	NULL
e08	NULL
)	NULL
NFATe.o	NULL
Rel	NULL
similariti	NULL
domain	NULL
l—GNAIFLTVSREHERVGCFF	NULL
(	NULL
rig	NULL
)	NULL
NFATos	NULL
___	NULL
ESS	NULL
LL_I	NULL
NFATo	NULL
.	NULL

«	NULL
_	NULL
ES-I	NULL
DOD	NULL
&	NULL
NFATp	NULL
orr	NULL
TA	NULL
N	NULL
P	NULL
NTA	NULL
__	NULL
he	NULL
Similerity	NULL
Domain	NULL
__|	NULL
NFATx/alc	NULL
#	NULL
Rel	NULL
Similarity	NULL
Domain	NULL
.	NULL

[	NULL
T	NULL
NFAT3	NULL
|TXEXS	NULL
]	NULL
_	NULL
Rel	NULL
Similarity	NULL
Domain	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Structural	NULL
similarities	NULL
and	NULL
dissimilarities	NULL
in	NULL
NFAT	NULL
family	NULL
members	NULL
.	NULL

A	NULL
,	NULL
amino	NULL
acid	NULL
composition	NULL
of	NULL
NFATe.S	NULL
unique	NULL
regions	NULL
is	NULL
compared	NULL
with	NULL
the	NULL
corresponding	NULL
regions	NULL
of	NULL
NFATe	NULL
.	NULL

«	NULL
.	NULL

Amino	NULL
acid	NULL
positions	NULL
where	NULL
sequence	NULL
diversion	NULL
starts	NULL
and	NULL
ends	NULL
are	NULL
indicated	NULL
.	NULL

B	NULL
,	NULL
schematic	NULL
comparison	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
members	NULL
.	NULL

Rel	NULL
similarity	NULL
domains	NULL
are	NULL
indicated	NULL
,	NULL
and	NULL
the	NULL
SP	NULL
repeat	NULL
motifs	NULL
are	NULL
represented	NULL
by	NULL
small	NULL
open	NULL
rectangles	NULL
.	NULL

Amino	NULL
acid	NULL
sequence	NULL
of	NULL
NFATe.f	NULL
is	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
NFATc	NULL
.	NULL

«	NULL
from	NULL
NH	NULL
,	NULL
terminus	NULL
to	NULL
the	NULL
Rel	NULL
similarity	NULL
domain	NULL
,	NULL
except	NULL
for	NULL
the	NULL
first	NULL
29	NULL
amino	NULL
acids	NULL
,	NULL
as	NULL
indicated	NULL
by	NULL
solid	NULL
bars	NULL
.	NULL

same	NULL
amounts	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
of	NULL
purified	NULL
proteins	NULL
were	NULL
separated	NULL
on	NULL
SDS-PAGE	NULL
and	NULL
stained	NULL
with	NULL
Coomassie	NULL
Brilliant	NULL
Blue	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
the	NULL
protein	NULL
preparations	NULL
exhibited	NULL
highly	NULL
purified	NULL
forms	NULL
although	NULL
there	NULL
was	NULL
evidence	NULL
of	NULL
partial	NULL
degradation	NULL
in	NULL
the	NULL
NFATc.B	NULL
(	NULL
214-814	NULL
)	NULL
recombinant	NULL
protein	NULL
.	NULL

Using	NULL
the	NULL
purified	NULL
NFATc.B	NULL
(	NULL
214-814	NULL
)	NULL
,	NULL
we	NULL
tested	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
of	NULL
NFAT	NULL
'	NULL
c.8	NULL
to	NULL
the	NULL
distal	NULL
NFAT	NULL
site	NULL
in	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
.	NULL

NFATe.B	NULL
was	NULL
unable	NULL
to	NULL
directly	NULL
bind	NULL
to	NULL
the	NULL
human	NULL
IL-2	NULL
NFAT	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
but	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Fos	NULL
and	NULL
Jun	NULL
proteins	NULL
,	NULL
could	NULL
form	NULL
an	NULL
NFAT	NULL
complex	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
previous	NULL
observations	NULL
of	NULL
NFAT	NULL
complex	NULL
formation	NULL
in	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
(	NULL
9	NULL
)	NULL
.	NULL

This	NULL
binding	NULL
was	NULL
sequence	NULL
specific	NULL
because	NULL
it	NULL
was	NULL
competed	NULL
away	NULL
with	NULL
excess	NULL
unlabeled	NULL
NFAT	NULL
oligonucleotides	NULL
,	NULL
but	NULL
not	NULL
with	NULL
nonspecific	NULL
or	NULL
mutant	NULL
NFAT	NULL
oligonucleotides	NULL
.	NULL

A	NULL
diffuse	NULL
band	NULL
pattern	NULL
is	NULL
likely	NULL
due	NULL
to	NULL
partial	NULL
degradation	NULL
of	NULL
the	NULL
purified	NULL
NFATc.B	NULL
(	NULL
214-814	NULL
)	NULL
protein	NULL
since	NULL
the	NULL
smaller	NULL
polypeptide	NULL
NFAT	NULL
'	NULL
c.B	NULL
(	NULL
214-703	NULL
)	NULL
which	NULL
showed	NULL
less	NULL
degradation	NULL
did	NULL
not	NULL
show	NULL
a	NULL
diffuse	NULL
band	NULL
pattern	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Requirement	NULL
of	NULL
Fos	NULL
and	NULL
Jun	NULL
for	NULL
in	NULL
Vitro	NULL
NFAT	NULL
Complex	NULL
Assembly-We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
both	NULL
Fos	NULL
and	NULL
Jun	NULL
were	NULL
required	NULL
for	NULL
efficient	NULL
in	NULL
vitro	NULL
reconstitution	NULL
of	NULL
NFAT	NULL
complex	NULL
with	NULL
pre-existing	NULL
NFAT	NULL
components	NULL
in	NULL
unstimulated	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
(	NULL
9	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
NFATe	NULL
.	NULL

$	NULL
exhibits	NULL
similar	NULL
properties	NULL
in	NULL
cooperative	NULL
binding	NULL
with	NULL
Fos	NULL
and	NULL
Jun	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
abilities	NULL
of	NULL
Fos/Jun	NULL
heterodimers	NULL
and	NULL
Jun/Jun	NULL
homodimers	NULL
to	NULL
reconstitute	NULL
an	NULL
NFAT	NULL
complex	NULL
with	NULL
NFATc.B	NULL
across	NULL
a	NULL
wide	NULL
concentration	NULL
range	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

NFAT	NULL
complex	NULL
assembly	NULL
was	NULL
efficiently	NULL
detected	NULL
at	NULL
lower	NULL
concentrations	NULL
of	NULL
Fos/Jun	NULL
heterodimers	NULL
than	NULL
that	NULL
of	NULL
Jun/Jun	NULL
homodimers	NULL
.	NULL

Comparison	NULL
of	NULL
band	NULL
intensities	NULL
between	NULL
NFAT	NULL
complexes	NULL
formed	NULL
with	NULL
Fos/Jun	NULL
and	NULL
Jun/Jun	NULL
dimers	NULL
indicated	NULL
that	NULL
the	NULL
ability	NULL
of	NULL
Fos/Jun	NULL
heterodimers	NULL
to	NULL
participate	NULL
in	NULL
the	NULL
cooperative	NULL
assem-	NULL
20917	NULL
©	NULL
£	NULL
i	NULL
®	NULL
co	NULL
30	NULL
$	NULL
€	NULL
©	NULL
Eo	NULL
g	NULL
@	NULL
Po=	NULL
=	NULL
80	NULL
_o	NULL
g	NULL
%	NULL
o	NULL
s	NULL
f	NULL
2	NULL
J	NULL
©	NULL
_s	NULL
2	NULL
E	NULL
8	NULL
5	NULL
&	NULL
8	NULL
E	NULL
Probe	NULL
7.5	NULL
we	NULL
»	NULL
a1-	NULL
-..	NULL
Common	NULL
sequence	NULL
of	NULL
.	NULL

NFATc.a	NULL
and	NULL
NFATc.B	NULL
2.4	NULL
-	NULL
.	NULL
'	NULL

7.5	NULL
|	NULL
4.4	NULL
-	NULL
UM	NULL
wt	NULL
~	NULL
»	NULL
in	NULL
NFATc.B	NULL
unique	NULL
sequence	NULL
2	NULL
.	NULL

A	NULL
2.4	NULL
G3PDH	NULL
z-	NULL
«	NULL
©	NULL
@	NULL
a	NULL
Fig	NULL
.	NULL

3.	NULL
mRNA	NULL
expression	NULL
of	NULL
two	NULL
NFATc	NULL
isoforms	NULL
in	NULL
different	NULL
human	NULL
tissues	NULL
.	NULL

A	NULL
Northern	NULL
blot	NULL
with	NULL
2	NULL
pg	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
®	NULL
RNA	NULL
from	NULL
different	NULL
human	NULL
tissues	NULL
was	NULL
hybridized	NULL
with	NULL
a	NULL
probe	NULL
derived	NULL
from	NULL
a	NULL
common	NULL
sequence	NULL
of	NULL
NFATc.a	NULL
and	NULL
NFATe.8	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
.	NULL

After	NULL
stripping	NULL
,	NULL
the	NULL
same	NULL
blot	NULL
was	NULL
rehybridized	NULL
with	NULL
an	NULL
unique	NULL
probe	NULL
(	NULL
middle	NULL
panel	NULL
)	NULL
,	NULL
and	NULL
subsequently	NULL
with	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
G3PDH	NULL
)	NULL
cDNA	NULL
probe	NULL
to	NULL
quantitate	NULL
amounts	NULL
of	NULL
RNA	NULL
loaded	NULL
per	NULL
lane	NULL
(	NULL
bottom	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
size	NULL
markers	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
.	NULL

bly	NULL
of	NULL
NFAT	NULL
complexes	NULL
was	NULL
higher	NULL
by	NULL
at	NULL
least	NULL
10-fold	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

CsA-sensitive	NULL
Activation	NULL
of	NULL
IL-2	NULL
NFAT	NULL
Site-dependent	NULL
Transcription	NULL
by	NULL
NFATc.B-Since	NULL
NFATc.B	NULL
was	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
IL-2	NULL
promoter	NULL
NFAT	NULL
site	NULL
,	NULL
we	NULL
investigated	NULL
its	NULL
transactivation	NULL
potential	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
.	NULL

An	NULL
NFATc.B	NULL
,	NULL
NFATp	NULL
,	NULL
or	NULL
a	NULL
control	NULL
expression	NULL
vector	NULL
was	NULL
cotransfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
with	NULL
a	NULL
reporter	NULL
gene	NULL
(	NULL
CAT	NULL
)	NULL
construct	NULL
containing	NULL
three	NULL
IL-2	NULL
NFAT	NULL
sites	NULL
upstream	NULL
of	NULL
a	NULL
minimal	NULL
y-fibrinogen	NULL
promoter	NULL
,	NULL
and	NULL
the	NULL
ability	NULL
to	NULL
activate	NULL
NFAT-dependent	NULL
transcription	NULL
was	NULL
tested	NULL
with	NULL
various	NULL
combinations	NULL
of	NULL
PMA	NULL
and	NULL
ionomycin	NULL
treatments	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

In	NULL
control	NULL
transfection	NULL
,	NULL
treatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
strongly	NULL
induced	NULL
CAT	NULL
expression	NULL
by	NULL
endogenous	NULL
NFAT	NULL
activity	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
induction	NULL
was	NULL
inhibited	NULL
by	NULL
CsA	NULL
.	NULL

Transfection	NULL
of	NULL
the	NULL
NFATe.B	NULL
expression	NULL
vector	NULL
resulted	NULL
in	NULL
approximately	NULL
2-fold	NULL
additional	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
,	NULL
and	NULL
more	NULL
importantly	NULL
,	NULL
the	NULL
induction	NULL
was	NULL
also	NULL
completely	NULL
blocked	NULL
by	NULL
CsA	NULL
.	NULL

Treatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
either	NULL
PMA	NULL
or	NULL
ionomycin	NULL
alone	NULL
failed	NULL
to	NULL
activate	NULL
the	NULL
IL-2	NULL
NFAT-dependent	NULL
transcription	NULL
.	NULL

NFATp	NULL
transfection	NULL
,	NULL
used	NULL
here	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
,	NULL
also	NULL
led	NULL
to	NULL
additional	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
by	NULL
approximately	NULL
2.3-fold	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
NFAT/CAT	NULL
reporter	NULL
construct	NULL
by	NULL
NFATe.f	NULL
in	NULL
Jurkat	NULL
cells	NULL
was	NULL
strictly	NULL
regulated	NULL
by	NULL
the	NULL
mechanisms	NULL
which	NULL
control	NULL
endogenous	NULL
NFAT	NULL
activity	NULL
,	NULL
and	NULL
that	NULL
was	NULL
also	NULL
sensitive	NULL
to	NULL
CsA	NULL
.	NULL

Lack	NULL
of	NULL
DNA	NULL
Binding	NULL
to	NULL
the	NULL
TNF-a	NULL
«	NULL
3	NULL
Element	NULL
and	NULL
Activation	NULL
of	NULL
the	NULL
TNF-	NULL
«	NULL
Promoter	NULL
by	NULL
NFATc.B-It	NULL
has	NULL
been	NULL
well	NULL
established	NULL
that	NULL
TNF-a	NULL
expression	NULL
was	NULL
induced	NULL
in	NULL
primary	NULL
B	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
in	NULL
numerous	NULL
B	NULL
cell	NULL
lines	NULL
by	NULL
various	NULL
cellular	NULL
stimuli	NULL
(	NULL
34	NULL
,	NULL
41	NULL
,	NULL
42	NULL
)	NULL
.	NULL

Rapid	NULL
induction	NULL
of	NULL
TNF-a	NULL
transcription	NULL
by	NULL
anti-Ig	NULL
was	NULL
blocked	NULL
by	NULL
CsA	NULL
and	NULL
FK506	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
34	NULL
)	NULL
.	NULL

The	NULL
«	NULL
3	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
20918	NULL
A	NULL
214-814	NULL
[	NULL
ZZZ	NULL
214-769	NULL
[	NULL
-__	NULL
_	NULL
___	NULL
NFATe.6	NULL
deletion	NULL
o	NULL
~	NULL
{	NULL
|__	NULL
Rel	NULL
Similarity	NULL
Domain	NULL
|/	NULL
|_	NULL
____	NULL
]	NULL
derivatives	NULL
214-703	NULL
[	NULL
LCIE	NULL
Rel	NULL
Similarity	NULL
domain	NULL
NFATpXS	NULL
(	NULL
1-297	NULL
)	NULL
NFAT	NULL
.	NULL

U	NULL
_	NULL
derivatives	NULL
in	NULL
TD	NULL
&	NULL
0	NULL
g	NULL
g	NULL
xf	NULL
A	NULL
in	NULL
F	NULL
hi	NULL
a	NULL
E	NULL
3	NULL
go	NULL
f	NULL
of	NULL
&	NULL
(	NULL
kDa	NULL
)	NULL
a	NULL
(	NULL
u	NULL
ou	NULL
S	NULL
Z	NULL
200	NULL
-|	NULL
|	NULL
(	NULL
Wy	NULL
97	NULL
-|	NULL
|	NULL
ame	NULL
68	NULL
--	NULL
as	NULL
-|	NULL
W	NULL
umd	NULL
20	NULL
-|	NULL
WW	NULL
C	NULL
<	NULL
4	NULL
E	NULL
Competitor	NULL
-	NULL
-	NULL
-	NULL
&	NULL
%	NULL
€	NULL
NFATe.3	NULL
Foos	NULL
040	NULL
oto	NULL
4	NULL
+	NULL
#	NULL
Fos/Jun	NULL
-o	NULL
t+	NULL
ob	NULL
ot	NULL
+	NULL
o+	NULL
¥	NULL
nd	NULL
%	NULL
@	NULL
10	NULL
2	NULL
30	NULL
40	NULL
50	NULL
6	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Generation	NULL
of	NULL
recombinant	NULL
NFATc.§6	NULL
deletion	NULL
mutants	NULL
and	NULL
their	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
to	NULL
the	NULL
IL-2	NULL
NFAT	NULL
site	NULL
.	NULL

A	NULL
,	NULL
schematic	NULL
representation	NULL
of	NULL
deletion	NULL
mutants	NULL
of	NULL
and	NULL
NFATp	NULL
peptides	NULL
used	NULL
for	NULL
DNA	NULL
binding	NULL
.	NULL

Three	NULL
deletion	NULL
derivatives	NULL
of	NULL
were	NULL
generated	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

The	NULL
numbers	NULL
refer	NULL
to	NULL
the	NULL
amino	NULL
acids	NULL
present	NULL
in	NULL
the	NULL
recombinant	NULL
proteins	NULL
.	NULL

B	NULL
,	NULL
purified	NULL
deletion	NULL
derivatives	NULL
of	NULL
NFATc.6	NULL
and	NULL
NFATp	NULL
.	NULL

Recombinant	NULL
proteins	NULL
tagged	NULL
with	NULL
a	NULL
hexahistidine	NULL
at	NULL
the	NULL
NH	NULL
,	NULL
terminus	NULL
were	NULL
expressed	NULL
in	NULL
E.	NULL
coli	NULL
,	NULL
and	NULL
purified	NULL
using	NULL
Ni-chelate	NULL
resin	NULL
as	NULL
de	NULL
Transcription	NULL
Factor	NULL
NFAT	NULL
Gene	NULL
Family	NULL
element	NULL
in	NULL
the	NULL
TNF-a	NULL
promoter	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
CsA-sensitive	NULL
induction	NULL
of	NULL
this	NULL
gene	NULL
,	NULL
and	NULL
NFATp	NULL
was	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
this	NULL
element	NULL
without	NULL
AP-1	NULL
proteins	NULL
,	NULL
suggesting	NULL
that	NULL
NFATp	NULL
is	NULL
involved	NULL
in	NULL
TNF-a	NULL
production	NULL
(	NULL
17	NULL
,	NULL
35	NULL
,	NULL
43	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
NFATe.B	NULL
rel	NULL
similarity	NULL
domain	NULL
is	NULL
closely	NULL
related	NULL
to	NULL
that	NULL
of	NULL
NFATp	NULL
and	NULL
was	NULL
cloned	NULL
from	NULL
B	NULL
cells	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
it	NULL
could	NULL
bind	NULL
to	NULL
the	NULL
«	NULL
3	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
previous	NULL
results	NULL
(	NULL
35	NULL
)	NULL
,	NULL
NFATp	NULL
binding	NULL
to	NULL
the	NULL
«	NULL
3	NULL
element	NULL
gave	NULL
rise	NULL
to	NULL
two	NULL
strong	NULL
NFATp-DNA	NULL
complexes	NULL
;	NULL
binding	NULL
of	NULL
one	NULL
or	NULL
two	NULL
NFATp	NULL
molecules	NULL
is	NULL
thought	NULL
to	NULL
give	NULL
rise	NULL
to	NULL
lower	NULL
and	NULL
upper	NULL
complexes	NULL
,	NULL
respectively	NULL
(	NULL
top	NULL
panel	NULL
,	NULL
lanes	NULL
10-12	NULL
)	NULL
.	NULL

Significantly	NULL
,	NULL
all	NULL
three	NULL
recombinant	NULL
derivatives	NULL
of	NULL
NFATe.B	NULL
were	NULL
unable	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
same	NULL
site	NULL
(	NULL
lanes	NULL
1-9	NULL
)	NULL
.	NULL

However	NULL
,	NULL
both	NULL
NFATp	NULL
and	NULL
NFATe.B	NULL
recombinant	NULL
proteins	NULL
showed	NULL
relatively	NULL
comparable	NULL
binding	NULL
affinities	NULL
to	NULL
the	NULL
human	NULL
IL-2	NULL
NFAT	NULL
site	NULL
(	NULL
bottom	NULL
panel	NULL
)	NULL
.	NULL

A	NULL
wide	NULL
range	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
concentrations	NULL
(	NULL
0-1	NULL
ug/reaction	NULL
)	NULL
did	NULL
not	NULL
change	NULL
binding	NULL
specificities	NULL
of	NULL
the	NULL
recombinant	NULL
proteins	NULL
to	NULL
the	NULL
«	NULL
3	NULL
element	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
inability	NULL
of	NULL
NFATc.8	NULL
deletion	NULL
derivatives	NULL
to	NULL
bind	NULL
to	NULL
this	NULL
site	NULL
is	NULL
not	NULL
due	NULL
to	NULL
a	NULL
high	NULL
concentration	NULL
of	NULL
nonspecific	NULL
competitor	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
used	NULL
in	NULL
this	NULL
experiment	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
results	NULL
demonstrate	NULL
that	NULL
NFATe.B	NULL
and	NULL
NFATp	NULL
exhibit	NULL
differences	NULL
in	NULL
binding	NULL
specificities	NULL
to	NULL
the	NULL
TNF-a	NULL
«	NULL
3	NULL
element	NULL
.	NULL

To	NULL
further	NULL
confirm	NULL
whether	NULL
NFATe.8	NULL
is	NULL
indeed	NULL
non-functional	NULL
in	NULL
in	NULL
vivo	NULL
activation	NULL
of	NULL
the	NULL
TNF-a	NULL
promoter	NULL
,	NULL
we	NULL
cotransfected	NULL
either	NULL
NFATc.f	NULL
or	NULL
NFATp	NULL
expression	NULL
plasmid	NULL
with	NULL
a	NULL
TNF-a	NULL
promoter-luciferase	NULL
reporter	NULL
plasmid	NULL
into	NULL
Jurkat	NULL
T	NULL
and	NULL
Raji	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
tested	NULL
their	NULL
ability	NULL
to	NULL
activate	NULL
the	NULL
TNF-	NULL
@	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

In	NULL
control	NULL
transfection	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
luciferase	NULL
activity	NULL
was	NULL
induced	NULL
by	NULL
about	NULL
25-fold	NULL
upon	NULL
stimulation	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
,	NULL
and	NULL
the	NULL
induction	NULL
was	NULL
inhibited	NULL
by	NULL
CsA	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
activation	NULL
of	NULL
the	NULL
TNF-a	NULL
promoter	NULL
is	NULL
sensitive	NULL
to	NULL
CsA	NULL
as	NULL
previously	NULL
shown	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Cotransfection	NULL
with	NULL
an	NULL
NFATp	NULL
expression	NULL
plasmid	NULL
further	NULL
increased	NULL
luciferase	NULL
activity	NULL
up	NULL
to	NULL
150-fold	NULL
in	NULL
a	NULL
CsA-sensitive	NULL
manner	NULL
.	NULL

However	NULL
,	NULL
NFATe.B	NULL
transfection	NULL
did	NULL
not	NULL
show	NULL
any	NULL
additional	NULL
induction	NULL
of	NULL
luciferase	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
observed	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
with	NULL
Raji	NULL
B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
Raji	NULL
cells	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
led	NULL
to	NULL
2-fold	NULL
induction	NULL
of	NULL
TNF-a	NULL
promoter-driven	NULL
luciferase	NULL
activity	NULL
in	NULL
the	NULL
control	NULL
transfection	NULL
.	NULL

It	NULL
is	NULL
important	NULL
to	NULL
point	NULL
out	NULL
that	NULL
the	NULL
low	NULL
levels	NULL
of	NULL
net	NULL
induction	NULL
of	NULL
luciferase	NULL
activity	NULL
by	NULL
stimulation	NULL
appears	NULL
to	NULL
be	NULL
due	NULL
to	NULL
strong	NULL
constitutive	NULL
activity	NULL
of	NULL
the	NULL
TNF-	NULL
@	NULL
promoter	NULL
in	NULL
Raji	NULL
cells	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
stimulation	NULL
,	NULL
TNF-	NULL
«	NULL
promoter-driven	NULL
luciferase	NULL
activity	NULL
in	NULL
Raji	NULL
cells	NULL
was	NULL
higher	NULL
by	NULL
approximately	NULL
7-fold	NULL
than	NULL
that	NULL
of	NULL
Jurkat	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
agree	NULL
with	NULL
the	NULL
observations	NULL
of	NULL
Goldfeld	NULL
et	NULL
al	NULL
.	NULL

(	NULL
42	NULL
)	NULL
who	NULL
showed	NULL
that	NULL
TNF-a	NULL
mRNA	NULL
was	NULL
constitutively	NULL
expressed	NULL
in	NULL
Raji	NULL
cells	NULL
which	NULL
could	NULL
be	NULL
further	NULL
enhanced	NULL
by	NULL
PMA	NULL
treatment	NULL
of	NULL
cells	NULL
.	NULL

NFATp	NULL
expression	NULL
increased	NULL
luciferase	NULL
activity	NULL
about	NULL
5-fold	NULL
without	NULL
stimulation	NULL
,	NULL
and	NULL
simulation	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
resulted	NULL
in	NULL
additional	NULL
induction	NULL
of	NULL
luciferase	NULL
activity	NULL
which	NULL
was	NULL
blocked	NULL
by	NULL
CsA	NULL
.	NULL

Like	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
NFATc.B	NULL
was	NULL
unable	NULL
to	NULL
activate	NULL
the	NULL
TNF-a	NULL
promoter	NULL
in	NULL
Raji	NULL
B	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
unlikely	NULL
that	NULL
lack	NULL
of	NULL
additional	NULL
induction	NULL
of	NULL
luciferase	NULL
activity	NULL
scribed	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Purified	NULL
proteins	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
gel	NULL
and	NULL
stained	NULL
with	NULL
Coomassie	NULL
Brilliant	NULL
Blue	NULL
.	NULL

Lane	NULL
1	NULL
contains	NULL
molecular	NULL
weight	NULL
markers	NULL
.	NULL

The	NULL
molecular	NULL
sizes	NULL
of	NULL
the	NULL
markers	NULL
(	NULL
kDa	NULL
)	NULL
are	NULL
indicated	NULL
on	NULL
fhe	NULL
left	NULL
.	NULL

C	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
was	NULL
performed	NULL
with	NULL
0.1	NULL
ug	NULL
of	NULL
purified	NULL
NFATc.B	NULL
(	NULL
214-814	NULL
)	NULL
with	NULL
or	NULL
without	NULL
100	NULL
nM	NULL
of	NULL
c-Fos/c-Jun	NULL
heterodimers	NULL
and	NULL
a	NULL
radiolabeled	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
distal	NULL
NFAT	NULL
site	NULL
in	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
.	NULL

To	NULL
assess	NULL
binding	NULL
specificity	NULL
,	NULL
unlabeled	NULL
oligonucleotides	NULL
bearing	NULL
nonspecific	NULL
sequence	NULL
(	NULL
NS	NULL
)	NULL
,	NULL
the	NULL
NFAT	NULL
site	NULL
(	NULL
NFAT	NULL
)	NULL
,	NULL
or	NULL
a	NULL
mutant	NULL
NFAT	NULL
site	NULL
(	NULL
mNFAT	NULL
)	NULL
were	NULL
added	NULL
to	NULL
the	NULL
assays	NULL
as	NULL
competitors	NULL
at	NULL
a	NULL
25-fold	NULL
molar	NULL
excess	NULL
.	NULL

Arrow	NULL
indicates	NULL
a	NULL
reconstituted	NULL
NFAT	NULL
complex	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Transcription	NULL
Factor	NULL
NFAT	NULL
Gene	NULL
Family	NULL
20919	NULL
2	NULL
00	NULL
NFATe.B	NULL
a	NULL
NFATe.8	NULL
5	NULL
§	NULL
+	NULL
5	NULL
4	NULL
[	NULL
TTC	NULL
]	NULL
NFATp	NULL
A	NULL
G	NULL
Fos/J	NULL
|	NULL
a	NULL
Jun/Jun	NULL
(	NULL
ul	NULL
)	NULL
P14814	NULL
214-769	NULL
214-703	NULL
,9	NULL
5	NULL
os/Jun	NULL
{	NULL
u	NULL
)	NULL
é	NULL
&	NULL
Binding	NULL
Site	NULL
|\|	NULL
I\	NULL
‘	NULL
<	NULL
o	NULL
3	NULL
is	NULL
$	NULL
I	NULL
01	NULL
05	NULL
1.0	NULL
20	NULL
4.0I	NULL
§	NULL
o1	NULL
os	NULL
10	NULL
20	NULL
40	NULL
-C	NULL
dimer	NULL
yea	NULL
r	NULL
.	NULL
'	NULL

x3	NULL
E-	NULL
.-	NULL
<	NULL
5	NULL
monomer	NULL
NFATe.f/p-	NULL
'	NULL
l	NULL
.	NULL

_	NULL
n-	NULL
j	NULL
Fos-Jun	NULL
IL-2	NULL
NFAT	NULL
6-8	NULL
«	NULL
«	NULL
-	NULL
**	NULL
``	NULL
``	NULL
E-	NULL
Fos-Jun	NULL
©600ee	NULL
a	NULL
-	NULL
.	NULL

eann0®©	NULL
1	NULL
2008	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
90	NULL
10	NULL
11	NULL
G20	NULL
13	NULL
FiG	NULL
.	NULL

5	NULL
.	NULL

Requirement	NULL
of	NULL
Fos	NULL
and	NULL
Jun	NULL
for	NULL
DNA	NULL
binding	NULL
of	NULL
NFATe.6	NULL
to	NULL
the	NULL
human	NULL
IL-2	NULL
NFAT	NULL
site	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
220	NULL
nm	NULL
NFATe.f	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
increasing	NULL
amounts	NULL
(	NULL
6-250	NULL
nM	NULL
)	NULL
of	NULL
Fos/Jun	NULL
heterodimers	NULL
or	NULL
Jun/Jun	NULL
homodimers	NULL
and	NULL
a	NULL
radiolabeled	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
human	NULL
IL-2	NULL
NFAT	NULL
site	NULL
.	NULL

Open	NULL
arrow	NULL
indicates	NULL
weak	NULL
binding	NULL
of	NULL
Fos/Jun	NULL
heterodimers	NULL
to	NULL
the	NULL
NFAT	NULL
site	NULL
,	NULL
and	NULL
closed	NULL
arrow	NULL
indicates	NULL
an	NULL
reconstituted	NULL
NFAT	NULL
complex	NULL
containing	NULL
NFATe.8	NULL
,	NULL
Fos	NULL
,	NULL
and	NULL
Jun	NULL
.	NULL

20	NULL
ﬁg	NULL
3	NULL
>	NULL
o	NULL
15-5	NULL
E	NULL
2	NULL
S	NULL
gs	NULL
10-3	NULL
s	NULL
)	NULL
a	NULL
|_	NULL
<	NULL
C	NULL
5-O	NULL
0—	NULL
Control	NULL
NFATp	NULL
Fic	NULL
.	NULL

6.	NULL
activates	NULL
transcription	NULL
of	NULL
an	NULL
IL-2	NULL
NFAT-dependent	NULL
reporter	NULL
gene	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
NFAT-CAT	NULL
plasmid	NULL
5B3.1	NULL
,	NULL
2.5	NULL
ug	NULL
of	NULL
hGH	NULL
expression	NULL
plasmid	NULL
,	NULL
and	NULL
15	NULL
ug	NULL
of	NULL
NFATe.§6	NULL
or	NULL
NFATp	NULL
expression	NULL
plasmid	NULL
.	NULL

At	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
either	NULL
unstimulated	NULL
(	NULL
minus	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
50	NULL
ng/ml	NULL
PMA	NULL
(	NULL
P	NULL
)	NULL
,	NULL
1.5	NULL
pM	NULL
ionomycin	NULL
(	NULL
F	NULL
)	NULL
,	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
(	NULL
P+1	NULL
)	NULL
,	NULL
or	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
plus	NULL
cyclosporin	NULL
A	NULL
(	NULL
P+I+CsA	NULL
)	NULL
for	NULL
additional	NULL
8	NULL
h	NULL
as	NULL
indicated	NULL
.	NULL

NFATp	NULL
transfection	NULL
was	NULL
carried	NULL
out	NULL
to	NULL
ensure	NULL
the	NULL
integrity	NULL
of	NULL
the	NULL
experimental	NULL
system	NULL
.	NULL

Control	NULL
transfections	NULL
were	NULL
performed	NULL
with	NULL
empty	NULL
expression	NULL
vectors	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
normalized	NULL
with	NULL
hGH	NULL
values	NULL
.	NULL

The	NULL
data	NULL
except	NULL
for	NULL
NFATp	NULL
transfection	NULL
represent	NULL
average	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

by	NULL
transfection	NULL
of	NULL
the	NULL
NFATc.B	NULL
expression	NULL
plasmid	NULL
is	NULL
due	NULL
to	NULL
failure	NULL
in	NULL
NFATc.f	NULL
expression	NULL
,	NULL
because	NULL
NFATc.f	NULL
expression	NULL
was	NULL
confirmed	NULL
by	NULL
immunoblotting	NULL
using	NULL
antibodies	NULL
raised	NULL
against	NULL
a	NULL
common	NULL
sequence	NULL
of	NULL
NFAT	NULL
'	NULL
c.a	NULL
«	NULL
and	NULL
NFATc	NULL
.	NULL

(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
transfection	NULL
of	NULL
the	NULL
same	NULL
expression	NULL
plas-	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
90	NULL
10	NULL
110	NULL
12	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

NFATe.6	NULL
binds	NULL
the	NULL
IL-2	NULL
NFAT	NULL
site	NULL
,	NULL
but	NULL
not	NULL
the	NULL
TNF-a	NULL
3	NULL
element	NULL
.	NULL

Increasing	NULL
amounts	NULL
of	NULL
three	NULL
NFAT	NULL
.	NULL

deletion	NULL
derivatives	NULL
or	NULL
an	NULL
NFAT	NULL
p	NULL
polypeptide	NULL
containing	NULL
the	NULL
rel	NULL
similarity	NULL
domain	NULL
were	NULL
mixed	NULL
with	NULL
radiolabeled	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
TNF-a	NULL
«	NULL
3	NULL
element	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
or	NULL
the	NULL
human	NULL
IL-2	NULL
NFAT	NULL
binding	NULL
site	NULL
(	NULL
bottom	NULL
panel	NULL
)	NULL
in	NULL
DNA	NULL
binding	NULL
reactions	NULL
.	NULL

Protein	NULL
amounts	NULL
of	NULL
indicated	NULL
peptides	NULL
were	NULL
increased	NULL
by	NULL
10-fold	NULL
ratio	NULL
in	NULL
each	NULL
lane	NULL
starting	NULL
with	NULL
1.3	NULL
nM	NULL
.	NULL

In	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
for	NULL
IL-2	NULL
NFAT	NULL
binding	NULL
,	NULL
200	NULL
nM	NULL
Fos/Jun	NULL
heterodimers	NULL
were	NULL
used	NULL
.	NULL

The	NULL
Fos/Jun	NULL
binding	NULL
to	NULL
the	NULL
IL-2	NULL
NFAT	NULL
site	NULL
(	NULL
bottom	NULL
panel	NULL
)	NULL
,	NULL
compared	NULL
to	NULL
a	NULL
weak	NULL
binding	NULL
in	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
is	NULL
due	NULL
to	NULL
a	NULL
higher	NULL
concentration	NULL
of	NULL
Fos/Jun	NULL
heterodimers	NULL
used	NULL
in	NULL
this	NULL
experiment	NULL
.	NULL

mid	NULL
activated	NULL
IL-2	NULL
NFAT-dependent	NULL
transcription	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
NFATc.8	NULL
is	NULL
not	NULL
involved	NULL
in	NULL
transcriptional	NULL
induction	NULL
of	NULL
the	NULL
TNF-a	NULL
gene	NULL
,	NULL
and	NULL
further	NULL
suggest	NULL
that	NULL
distinct	NULL
members	NULL
or	NULL
isoforms	NULL
of	NULL
NFAT	NULL
gene	NULL
family	NULL
may	NULL
regulate	NULL
different	NULL
NFAT	NULL
cis-acting	NULL
elements	NULL
located	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
cytokine	NULL
genes	NULL
.	NULL

DISCUSSION	NULL
Several	NULL
studies	NULL
have	NULL
demonstrated	NULL
existence	NULL
of	NULL
a	NULL
single	NULL
or	NULL
multiple	NULL
NFAT	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
regulatory	NULL
regions	NULL
of	NULL
several	NULL
cytokine	NULL
genes	NULL
including	NULL
IL-2	NULL
,	NULL
IL-3	NULL
,	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
granulo-cyte/macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
and	NULL
TNF-a	NULL
(	NULL
11-17	NULL
;	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

2	NULL
)	NULL
.	NULL

These	NULL
cytokines	NULL
are	NULL
distinctly	NULL
expressed	NULL
by	NULL
both	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
(	NULL
15	NULL
)	NULL
,	NULL
and	NULL
non-T	NULL
immune	NULL
cells	NULL
also	NULL
produce	NULL
some	NULL
of	NULL
these	NULL
cytokines	NULL
in	NULL
a	NULL
CsA-sensitive	NULL
manner	NULL
(	NULL
30	NULL
,	NULL
31	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Several	NULL
structurally	NULL
related	NULL
NFAT	NULL
family	NULL
proteins	NULL
have	NULL
recently	NULL
been	NULL
identified	NULL
and	NULL
characterized	NULL
.	NULL

This	NULL
raises	NULL
an	NULL
intriguing	NULL
question	NULL
regarding	NULL
the	NULL
roles	NULL
of	NULL
multiple	NULL
NFAT	NULL
proteins	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
cytokine	NULL
genes	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
report	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
new	NULL
NFAT	NULL
protein	NULL
which	NULL
might	NULL
be	NULL
a	NULL
product	NULL
of	NULL
alternative	NULL
splicing	NULL
and/or	NULL
differential	NULL
promoter	NULL
usage	NULL
in	NULL
the	NULL
gene	NULL
for	NULL
the	NULL
previously	NULL
identified	NULL
member	NULL
NFATc	NULL
(	NULL
NFATc.a	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
our	NULL
study	NULL
provides	NULL
evidence	NULL
that	NULL
this	NULL
new	NULL
NFAT	NULL
protein	NULL
does	NULL
not	NULL
participate	NULL
in	NULL
transcriptional	NULL
induction	NULL
of	NULL
TNF-a	NULL
,	NULL
while	NULL
it	NULL
still	NULL
activates	NULL
the	NULL
IL-2	NULL
NFAT-medi-ated	NULL
transcription	NULL
in	NULL
a	NULL
CsA-sensitive	NULL
manner	NULL
.	NULL

The	NULL
new	NULL
isoform	NULL
NFATc.B	NULL
resembles	NULL
NFAT	NULL
'	NULL
c.	NULL
«	NULL
in	NULL
that	NULL
it	NULL
has	NULL
an	NULL
identical	NULL
rel	NULL
similarity	NULL
region	NULL
and	NULL
its	NULL
entire	NULL
region	NULL
except	NULL
the	NULL
first	NULL
29	NULL
amino	NULL
acids	NULL
which	NULL
exhibit	NULL
a	NULL
high	NULL
acidic	NULL
amino	NULL
acid	NULL
content	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
corresponding	NULL
region	NULL
of	NULL
NFATc.a	NULL
contains	NULL
only	NULL
3	NULL
acidic	NULL
amino	NULL
acids	NULL
out	NULL
of	NULL
42	NULL
residues	NULL
,	NULL
and	NULL
displays	NULL
no	NULL
significant	NULL
sequence	NULL
similarity	NULL
to	NULL
the	NULL
NFATc.6	NULL
NH	NULL
,	NULL
terminus	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
a	NULL
deletion	NULL
mutant	NULL
of	NULL
NFAT	NULL
'	NULL
c.a	NULL
containing	NULL
the	NULL
NH	NULL
,	NULL
-terminal	NULL
region	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
418	NULL
upstream	NULL
of	NULL
rel	NULL
similarity	NULL
domain	NULL
)	NULL
has	NULL
been	NULL
previously	NULL
shown	NULL
to	NULL
display	NULL
a	NULL
dominant	NULL
negative	NULL
effect	NULL
on	NULL
the	NULL
IL-2	NULL
NFAT	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
20920	NULL
A	NULL
Jurkat	NULL
200	NULL
>	NULL
E	NULL
150	NULL
3	NULL
Fe	NULL
©	NULL
®	NULL
$	NULL
100	NULL
$	NULL
'	NULL
o	NULL
hel	NULL
_	NULL
]	NULL
$	NULL
0	NULL
s-	NULL
<	NULL
%	NULL
_|	NULL
P+L	NULL
P+	NULL
P+IL	NULL
P+I	NULL
-	NULL
PiL	NULL
PH	NULL
|	NULL
+CsA	NULL
Po	NULL
+CsA	NULL
Pol	NULL
+CsA	NULL
[	NULL
Control	NULL
NFATc.B	NULL
NFATp	NULL
Transcription	NULL
Factor	NULL
NFAT	NULL
Gene	NULL
Family	NULL
B	NULL
Raji	NULL
15	NULL
2	NULL
.s	NULL
0	NULL
10	NULL
-I	NULL
<	NULL
C	NULL
©	NULL
Pr	NULL
C	NULL
ko	NULL
2	NULL
'	NULL
o	NULL
3	NULL
21005	NULL
®	NULL
.2	NULL
s	NULL
©	NULL
CC	NULL
0	NULL
-	NULL
P+	NULL
P+	NULL
P+IL	NULL
PH	NULL
P+L	NULL
PHI	NULL
+CsA	NULL
+CsA	NULL
+CsA	NULL
L	NULL
1	NULL
|	NULL
1	NULL
1	NULL
I	NULL
Control	NULL
NFATo.8	NULL
NFATp	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

NFATe.§	NULL
fails	NULL
to	NULL
activate	NULL
the	NULL
TNF-a	NULL
promoter	NULL
.	NULL

A	NULL
TNF-a	NULL
promoter-luciferase	NULL
plasmid	NULL
was	NULL
transiently	NULL
cotransfected	NULL
into	NULL
Jurkat	NULL
T	NULL
and	NULL
Raji	NULL
B	NULL
cells	NULL
with	NULL
either	NULL
NFATe.6	NULL
or	NULL
NFATp	NULL
expression	NULL
plasmid	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

At	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
either	NULL
untreated	NULL
(	NULL
minus	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
50	NULL
ng/ml	NULL
PMA	NULL
plus	NULL
1.5	NULL
um	NULL
ionomycin	NULL
(	NULL
P+Z	NULL
)	NULL
or	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
plus	NULL
cyclosporin	NULL
A	NULL
for	NULL
additional	NULL
8	NULL
h	NULL
as	NULL
indicated	NULL
.	NULL

NFATp	NULL
transfection	NULL
was	NULL
done	NULL
to	NULL
ensure	NULL
the	NULL
integrity	NULL
of	NULL
the	NULL
experimental	NULL
system	NULL
.	NULL

Control	NULL
transfections	NULL
were	NULL
performed	NULL
with	NULL
empty	NULL
expression	NULL
vectors	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
normalized	NULL
with	NULL
hGH	NULL
values	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
represent	NULL
average	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

Standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
is	NULL
indicated	NULL
by	NULL
error	NULL
bars	NULL
.	NULL

dependent	NULL
transcription	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
will	NULL
be	NULL
interesting	NULL
to	NULL
elucidate	NULL
whether	NULL
the	NULL
29-amino	NULL
acid	NULL
substitution	NULL
with	NULL
high	NULL
acidic	NULL
content	NULL
will	NULL
impart	NULL
any	NULL
functional	NULL
differences	NULL
.	NULL

Another	NULL
distinct	NULL
region	NULL
of	NULL
NFATc	NULL
.	NULL

lies	NULL
in	NULL
the	NULL
additional	NULL
142	NULL
amino	NULL
acids	NULL
downstream	NULL
from	NULL
the	NULL
rel	NULL
similarity	NULL
domain	NULL
which	NULL
is	NULL
missing	NULL
in	NULL
NFATe	NULL
.	NULL

«	NULL
.	NULL

A	NULL
comparison	NULL
of	NULL
primary	NULL
sequences	NULL
of	NULL
all	NULL
NFAT	NULL
family	NULL
members	NULL
except	NULL
NFATc	NULL
.	NULL

«	NULL
reveals	NULL
that	NULL
they	NULL
form	NULL
a	NULL
tripartite	NULL
structure	NULL
consisting	NULL
of	NULL
the	NULL
well	NULL
conserved	NULL
rel	NULL
similarity	NULL
domain	NULL
,	NULL
the	NULL
moderately	NULL
conserved	NULL
NH	NULL
,	NULL
terminus	NULL
,	NULL
and	NULL
the	NULL
COOH	NULL
terminus	NULL
with	NULL
no	NULL
significant	NULL
sequence	NULL
homol-ogy	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
NFATc	NULL
.	NULL

86	NULL
appears	NULL
to	NULL
resemble	NULL
more	NULL
closely	NULL
other	NULL
members	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
in	NULL
its	NULL
primary	NULL
structure	NULL
than	NULL
NFATe	NULL
.	NULL

«	NULL
.	NULL

The	NULL
rel	NULL
similarity	NULL
domain	NULL
is	NULL
sufficient	NULL
for	NULL
DNA	NULL
binding	NULL
and	NULL
cooperative	NULL
interactions	NULL
with	NULL
AP-1	NULL
proteins	NULL
(	NULL
21	NULL
,	NULL
36	NULL
)	NULL
,	NULL
and	NULL
the	NULL
NH	NULL
,	NULL
terminus	NULL
containing	NULL
the	NULL
conserved	NULL
SP	NULL
repeat	NULL
motifs	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
other	NULL
common	NULL
function	NULL
(	NULL
s	NULL
)	NULL
such	NULL
as	NULL
transcription	NULL
activation	NULL
and/or	NULL
regulation	NULL
of	NULL
nuclear	NULL
translocation	NULL
(	NULL
21	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
significance	NULL
of	NULL
COOH-terminal	NULL
regions	NULL
of	NULL
these	NULL
molecules	NULL
remains	NULL
poorly	NULL
understood	NULL
.	NULL

The	NULL
extended	NULL
COOH-terminal	NULL
region	NULL
does	NULL
not	NULL
display	NULL
any	NULL
significant	NULL
sequence	NULL
similarity	NULL
among	NULL
the	NULL
family	NULL
members	NULL
,	NULL
and	NULL
we	NULL
could	NULL
not	NULL
discern	NULL
any	NULL
significant	NULL
differences	NULL
in	NULL
DNA	NULL
binding	NULL
abilities	NULL
of	NULL
NFATc.§	NULL
deletion	NULL
derivatives	NULL
in	NULL
this	NULL
region	NULL
at	NULL
least	NULL
to	NULL
NFAT-binding	NULL
sites	NULL
in	NULL
the	NULL
IL-2	NULL
and	NULL
TNF-a	NULL
promoters	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
this	NULL
region	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
regulation	NULL
of	NULL
activity	NULL
of	NULL
NFAT	NULL
proteins	NULL
by	NULL
interacting	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
or	NULL
by	NULL
influencing	NULL
half-life	NULL
of	NULL
NFAT	NULL
proteins	NULL
.	NULL

Further	NULL
experiments	NULL
will	NULL
delineate	NULL
the	NULL
exact	NULL
function	NULL
of	NULL
this	NULL
region	NULL
.	NULL

The	NULL
two	NULL
isoforms	NULL
,	NULL
NFATc	NULL
.	NULL

«	NULL
and	NULL
NFATe.B	NULL
,	NULL
could	NULL
also	NULL
be	NULL
distinguished	NULL
by	NULL
their	NULL
respective	NULL
mRNAs	NULL
.	NULL

Northern	NULL
blots	NULL
containing	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
RNA	NULL
from	NULL
numerous	NULL
human	NULL
tissues	NULL
always	NULL
showed	NULL
two	NULL
mRNA	NULL
species	NULL
with	NULL
the	NULL
sizes	NULL
of	NULL
2.7	NULL
and	NULL
4.5	NULL
kb	NULL
when	NULL
hybridized	NULL
with	NULL
a	NULL
probe	NULL
derived	NULL
from	NULL
common	NULL
sequences	NULL
of	NULL
NFATc	NULL
.	NULL

«	NULL
and	NULL
NFATe.f	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
an	NULL
NFATc.f-unique	NULL
probe	NULL
detected	NULL
only	NULL
the	NULL
4.5-kb	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
expression	NULL
profile	NULL
of	NULL
both	NULL
mRNAs	NULL
in	NULL
multiple	NULL
human	NULL
tissues	NULL
was	NULL
distinct	NULL
.	NULL

Although	NULL
both	NULL
mRNAs	NULL
were	NULL
expressed	NULL
in	NULL
various	NULL
tissues	NULL
,	NULL
NFAT	NULL
'	NULL
c.	NULL
«	NULL
mRNA	NULL
was	NULL
predominantly	NULL
expressed	NULL
in	NULL
the	NULL
thymus	NULL
and	NULL
peripheral	NULL
leukocytes	NULL
enriched	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
whereas	NULL
NFATc	NULL
.	NULL

B	NULL
mRNA	NULL
was	NULL
a	NULL
major	NULL
species	NULL
in	NULL
the	NULL
spleen	NULL
and	NULL
non-immune	NULL
tissues	NULL
.	NULL

Since	NULL
splenic	NULL
cells	NULL
consist	NULL
of	NULL
enriched	NULL
B	NULL
cell	NULL
population	NULL
,	NULL
it	NULL
is	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
B	NULL
cells	NULL
are	NULL
a	NULL
major	NULL
contributor	NULL
to	NULL
NFATc.B	NULL
mRNA	NULL
in	NULL
the	NULL
spleen	NULL
.	NULL

Failure	NULL
to	NULL
detect	NULL
NFAT	NULL
'	NULL
c.8	NULL
mRNA	NULL
in	NULL
peripheral	NULL
leukocytes	NULL
may	NULL
be	NULL
due	NULL
to	NULL
a	NULL
low	NULL
number	NULL
of	NULL
B	NULL
cells	NULL
(	NULL
7-10	NULL
%	NULL
)	NULL
contributing	NULL
to	NULL
a	NULL
poor	NULL
hybridizing	NULL
signal	NULL
.	NULL

Further	NULL
experiments	NULL
to	NULL
examine	NULL
cell	NULL
type-specific	NULL
NFATc.B	NULL
expression	NULL
are	NULL
currently	NULL
under	NULL
way	NULL
.	NULL

Significantly	NULL
,	NULL
our	NULL
present	NULL
data	NULL
demonstrate	NULL
that	NULL
NFATe.B	NULL
was	NULL
unable	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
TNF-a	NULL
«	NULL
3	NULL
element	NULL
to	NULL
which	NULL
NFATp	NULL
strongly	NULL
bound	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
transient	NULL
transfection	NULL
assays	NULL
indicate	NULL
that	NULL
indeed	NULL
was	NULL
non-functional	NULL
in	NULL
in	NULL
vivo	NULL
activation	NULL
of	NULL
the	NULL
TNF-a	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
findings	NULL
strongly	NULL
suggest	NULL
that	NULL
distinct	NULL
NFAT	NULL
proteins	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
regulation	NULL
of	NULL
different	NULL
cytokine	NULL
gene	NULL
expression	NULL
,	NULL
although	NULL
there	NULL
is	NULL
some	NULL
functional	NULL
redundancy	NULL
in	NULL
transcriptional	NULL
activation	NULL
of	NULL
a	NULL
certain	NULL
cytokine	NULL
gene	NULL
such	NULL
as	NULL
IL-2	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
NFAT	NULL
sites	NULL
in	NULL
the	NULL
regulatory	NULL
regions	NULL
of	NULL
different	NULL
cytokine	NULL
genes	NULL
display	NULL
some	NULL
divergence	NULL
in	NULL
their	NULL
sequence	NULL
and	NULL
properties	NULL
to	NULL
interact	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Many	NULL
NFAT	NULL
protein-binding	NULL
sites	NULL
are	NULL
flanked	NULL
by	NULL
a	NULL
cryptic	NULL
AP-1	NULL
site	NULL
,	NULL
while	NULL
some	NULL
others	NULL
such	NULL
as	NULL
those	NULL
in	NULL
the	NULL
IL-4	NULL
and	NULL
TNF-	NULL
@	NULL
promoters	NULL
are	NULL
adjacent	NULL
to	NULL
binding	NULL
sites	NULL
for	NULL
other	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
Oct	NULL
and	NULL
ATF/Jun	NULL
,	NULL
respectively	NULL
(	NULL
13	NULL
,	NULL
44	NULL
)	NULL
.	NULL

Partic-ularly	NULL
,	NULL
TNF-a	NULL
«	NULL
3	NULL
element	NULL
is	NULL
considerably	NULL
divergent	NULL
in	NULL
sequence	NULL
from	NULL
other	NULL
NFAT	NULL
sites	NULL
and	NULL
resembles	NULL
an	NULL
NF-KB	NULL
site	NULL
.	NULL

This	NULL
site	NULL
is	NULL
occupied	NULL
by	NULL
two	NULL
molecules	NULL
of	NULL
NFATp	NULL
that	NULL
appear	NULL
to	NULL
form	NULL
a	NULL
functional	NULL
dimer	NULL
for	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
TNF-a	NULL
gene	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
NFAT	NULL
p	NULL
molecules	NULL
bound	NULL
to	NULL
the	NULL
«	NULL
3	NULL
element	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
functionally	NULL
cooperate	NULL
with	NULL
ATF/Jun	NULL
proteins	NULL
in	NULL
immediate	NULL
early	NULL
induction	NULL
of	NULL
TNF-a	NULL
gene	NULL
transcription	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
mutually	NULL
exclusive	NULL
regulation	NULL
of	NULL
cell	NULL
type-specific	NULL
lymphokine	NULL
production	NULL
may	NULL
involve	NULL
recruitment	NULL
of	NULL
distinct	NULL
NFAT	NULL
family	NULL
members	NULL
as	NULL
well	NULL
as	NULL
sequential	NULL
or	NULL
combina-torial	NULL
participation	NULL
of	NULL
different	NULL
NFAT	NULL
proteins	NULL
and	NULL
other	NULL
transcription	NULL
factors	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Dr.	NULL
Abby	NULL
Maizel	NULL
for	NULL
thoughtful	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
and	NULL
for	NULL
the	NULL
continued	NULL
support	NULL
;	NULL
Drs	NULL
.	NULL

Anjana	NULL
Rao	NULL
,	NULL
Patrick	NULL
Hogan	NULL
,	NULL
and	NULL
Jugnu	NULL
Jain	NULL
for	NULL
providing	NULL
NFATp	NULL
reagents	NULL
and	NULL
a	NULL
TNF-	NULL
«	NULL
promoter-luciferase	NULL
construct	NULL
;	NULL
Drs	NULL
.	NULL

Tom	NULL
Curran	NULL
and	NULL
Tom	NULL
Kerppola	NULL
for	NULL
providing	NULL
recombinant	NULL
Fos	NULL
and	NULL
Jun	NULL
proteins	NULL
;	NULL
Dr.	NULL
Gerald	NULL
Crabtree	NULL
for	NULL
providing	NULL
an	NULL
NFAT-CAT	NULL
plasmid	NULL
,	NULL
Dr.	NULL
Timothy	NULL
Hoey	NULL
for	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Transcription	NULL
Factor	NULL
NFAT	NULL
Gene	NULL
Family	NULL
NFATe	NULL
antibody	NULL
,	NULL
and	NULL
Dr.	NULL
Alan	NULL
Rosmarin	NULL
for	NULL
helping	NULL
us	NULL
with	NULL
luciferase	NULL
assays	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Mark	NULL
Sanders	NULL
for	NULL
DNA	NULL
sequencing	NULL
and	NULL
Dr.	NULL
Robert	NULL
Ireland	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

co	NULL
Ro	NULL
|A	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

REFERENCES	NULL
.	NULL

Schreiber	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
18	NULL
,	NULL
136-142	NULL
.	NULL

Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
15	NULL
,	NULL
274-281	NULL
.	NULL

Serfling	NULL
,	NULL
E.	NULL
,	NULL
Avots	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Neumann	NULL
,	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1263	NULL
,	NULL
181-200	NULL
.	NULL

Flanagan	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
Corthésy	NULL
,	NULL
B.	NULL
,	NULL
Bram	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
852	NULL
,	NULL
803-807	NULL
.	NULL

Shaw	NULL
,	NULL
K	NULL
.	NULL

T.-Y	NULL
.	NULL

,	NULL
Ho	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Raghavan	NULL
,	NULL
A.	NULL
,	NULL
Kim	NULL
,	NULL
J.	NULL
,	NULL
Jain	NULL
,	NULL
J.	NULL
,	NULL
Park	NULL
,	NULL
J.	NULL
,	NULL
Sharma	NULL
,	NULL
S.	NULL
,	NULL
Rao	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Hogan	NULL
,	NULL
P.	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.A.	NULL
92	NULL
,	NULL
11205-11209	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Valge	NULL
,	NULL
A.	NULL
V.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nature	NULL
3856	NULL
,	NULL
801-804	NULL
.	NULL

Boise	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
Petryniak	NULL
,	NULL
B.	NULL
,	NULL
Mao	NULL
,	NULL
X.	NULL
,	NULL
June	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Wang	NULL
,	NULL
C.-Y	NULL
.	NULL

,	NULL
Lindsten	NULL
,	NULL
T.	NULL
,	NULL
Bravo	NULL
,	NULL
R.	NULL
,	NULL
Kovary	NULL
,	NULL
K.	NULL
,	NULL
Leiden	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Thompson	NULL
,	NULL
C.	NULL
B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
1911-1919	NULL
.	NULL

Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Ullman	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
2917-2923	NULL
.	NULL

Yaseen	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
Park	NULL
,	NULL
J.	NULL
,	NULL
Kerppola	NULL
,	NULL
T.	NULL
,	NULL
Curran	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Sharma	NULL
,	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
6886-6895	NULL
Jain	NULL
,	NULL
J.	NULL
,	NULL
Nalefski	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Johnson	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
Spiegelman	NULL
,	NULL
B.	NULL
M.	NULL
,	NULL
Papaioannou	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
1566-1574	NULL
Cockerill	NULL
,	NULL
P.	NULL
N.	NULL
,	NULL
Shannon	NULL
,	NULL
F.	NULL
,	NULL
Bert	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Ryan	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Vadas	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
2466-2470	NULL
Masuda	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
Tokumitsu	NULL
,	NULL
H.	NULL
,	NULL
Tsuboi	NULL
,	NULL
A.	NULL
,	NULL
Shlomai	NULL
,	NULL
J.	NULL
,	NULL
Hung	NULL
,	NULL
P.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
I.	NULL
,	NULL
and	NULL
Arai	NULL
,	NULL
N.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
7399-7407	NULL
Chuypilo	NULL
,	NULL
S.	NULL
,	NULL
Schomberg	NULL
,	NULL
C.	NULL
,	NULL
Gerwig	NULL
,	NULL
R.	NULL
,	NULL
Heinfling	NULL
,	NULL
A.	NULL
,	NULL
Reeves	NULL
,	NULL
R.	NULL
,	NULL
Grummt	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Serfling	NULL
,	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21	NULL
,	NULL
5694-5704	NULL
Szabo	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Gold	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Murphy	NULL
,	NULL
T.	NULL
L.	NULL
,	NULL
and	NULL
Murphy	NULL
,	NULL
K.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
4793-4805	NULL
Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Hodge	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Rao	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

18	NULL
,	NULL
625-633	NULL
Lee	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Masuda	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
Arai	NULL
,	NULL
N.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Yokota	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
17541-17550	NULL
Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Strominger	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178	NULL
,	NULL
1365-1379	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Luo	NULL
,	NULL
C.	NULL
,	NULL
Kerppola	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
Jain	NULL
,	NULL
J.	NULL
,	NULL
Badalian	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Ho	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Burgeon	NULL
,	NULL
E.	NULL
,	NULL
Lane	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Lambert	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Curran	NULL
,	NULL
T.	NULL
,	NULL
Verdine	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Rao	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Hogan	NULL
,	NULL
P.	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
750-754	NULL
Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Ho	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
Chen	NULL
,	NULL
L.	NULL
,	NULL
Thomas	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Timmerman	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Admon	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
369	NULL
,	NULL
497-502	NULL
Masuda	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
Naito	NULL
,	NULL
Y.	NULL
,	NULL
Tokumitsu	NULL
,	NULL
H.	NULL
,	NULL
Campbell	NULL
,	NULL
D.	NULL
,	NULL
Saito	NULL
,	NULL
F.	NULL
,	NULL
Hannum	NULL
,	NULL
C.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Arai	NULL
,	NULL
N.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
2697-2706	NULL
21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

20921	NULL
Hoey	NULL
,	NULL
T.	NULL
,	NULL
Sun	NULL
,	NULL
Y.-L.	NULL
,	NULL
Williamson	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Xu	NULL
,	NULL
X	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Immunity	NULL
2	NULL
,	NULL
461-472	NULL
Ho	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
Thomas	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Timmerman	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Li	NULL
,	NULL
X.	NULL
,	NULL
Francke	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
19898-19907	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
77	NULL
,	NULL
795-798	NULL
Jain	NULL
,	NULL
J.	NULL
,	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Miner	NULL
,	NULL
Z.	NULL
,	NULL
Kerppola	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
Lambert	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Verdine	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Curran	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Nature	NULL
365	NULL
,	NULL
352-355	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Perrino	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Soderling	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
3747-3752	NULL
Park	NULL
,	NULL
J.	NULL
,	NULL
Yaseen	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
Hogan	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Rao	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Sharma	NULL
,	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
20653-20659	NULL
Yaseen	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
Maizel	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Wang	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Sharma	NULL
,	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
14285-14293	NULL
Venkataraman	NULL
,	NULL
L.	NULL
,	NULL
Francis	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Wang	NULL
,	NULL
Z.	NULL
,	NULL
Liu	NULL
,	NULL
J.	NULL
,	NULL
Rothstein	NULL
,	NULL
T.	NULL
L.	NULL
,	NULL
and	NULL
Sen	NULL
,	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Immunity	NULL
1	NULL
,	NULL
189-196	NULL
Choi	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Brines	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
Holman	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Klaus	NULL
,	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
Immunity	NULL
1	NULL
,	NULL
179-187	NULL
Aramburu	NULL
,	NULL
J.	NULL
,	NULL
Azzoni	NULL
,	NULL
L.	NULL
,	NULL
Rao	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Perussia	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

182	NULL
,	NULL
801-810	NULL
Weiss	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Hural	NULL
,	NULL
J.	NULL
,	NULL
Tara	NULL
,	NULL
D.	NULL
,	NULL
Timmerman	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Henkel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Brown	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
228-235	NULL
Ho	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Jain	NULL
,	NULL
J.	NULL
,	NULL
Rao	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Hogan	NULL
,	NULL
P.	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
28181-28186	NULL
Klaus	NULL
,	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
Transplantation	NULL
46	NULL
,	NULL
118-148	NULL
Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
Flemingtn	NULL
,	NULL
E.	NULL
K.	NULL
,	NULL
Boussiotis	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
Theodos	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Titus	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
Strominger	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Speck	NULL
,	NULL
8	NULL
.	NULL

H.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
12198-12201	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
30445-30450	NULL
Jain	NULL
,	NULL
J.	NULL
,	NULL
Burgeon	NULL
,	NULL
E.	NULL
,	NULL
Badalian	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Hogan	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
4138-4145	NULL
Abate	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Luk	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Curran	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
3624-3632	NULL
Takebe	NULL
,	NULL
Y.	NULL
,	NULL
Seiki	NULL
,	NULL
M.	NULL
,	NULL
Fujisawa	NULL
,	NULL
J.-L.	NULL
,	NULL
Hoy	NULL
,	NULL
P.	NULL
,	NULL
Yokota	NULL
,	NULL
K.	NULL
,	NULL
Arai	NULL
,	NULL
K.-I	NULL
.	NULL

,	NULL
Yoshida	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Arai	NULL
,	NULL
N.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
466-472	NULL
Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Shaw	NULL
,	NULL
J.-P.	NULL
,	NULL
Bush	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Replogle	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Belagaje	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
1715-1724	NULL
Nedwin	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
Naylor	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Sakaguchi	NULL
,	NULL
A.	NULL
Y.	NULL
,	NULL
Smith	NULL
,	NULL
D.	NULL
,	NULL
Jarrett-Nedwin	NULL
,	NULL
J.	NULL
,	NULL
Pennica	NULL
,	NULL
D.	NULL
,	NULL
Goeddel	NULL
,	NULL
D.	NULL
V.	NULL
,	NULL
and	NULL
Gray	NULL
,	NULL
P.	NULL
W.	NULL
(	NULL
1985	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18	NULL
,	NULL
6361-6373	NULL
Sung	NULL
,	NULL
S.-S.	NULL
J.	NULL
,	NULL
Jung	NULL
,	NULL
L.	NULL
K.	NULL
L.	NULL
,	NULL
Walters	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Chen	NULL
,	NULL
W.	NULL
,	NULL
Wang	NULL
,	NULL
C.	NULL
Y.	NULL
,	NULL
and	NULL
Fu	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

168	NULL
,	NULL
1539-1551	NULL
Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
Strominger	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Doyle	NULL
,	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

174	NULL
,	NULL
73-81	NULL
Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
Tsai	NULL
,	NULL
E.	NULL
,	NULL
Kincaid	NULL
,	NULL
R.	NULL
,	NULL
Belshaw	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Schreiber	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Strominger	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180	NULL
,	NULL
763-768	NULL
Tsai	NULL
,	NULL
E.	NULL
Y.	NULL
,	NULL
Jain	NULL
,	NULL
J.	NULL
,	NULL
Pesavento	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Rao	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
459-467	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Characterization	NULL
of	NULL
a	NULL
New	NULL
Isoform	NULL
of	NULL
the	NULL
NFAT	NULL
(	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
Cells	NULL
)	NULL
Gene	NULL
Family	NULL
Member	NULL
NFATc	NULL
Jungchan	NULL
Park	NULL
,	NULL
Atsuko	NULL
Takeuchi	NULL
and	NULL
Surendra	NULL
Sharma	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1996	NULL
,	NULL
271:20914-20921.	NULL
doi	NULL
:	NULL
10.1074/jb0.271.34.20914	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/271/34/20914	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
44	NULL
references	NULL
,	NULL
29	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Additions	NULL
and	NULL
Corrections	NULL
Vol	NULL
.	NULL

271	NULL
(	NULL
1996	NULL
)	NULL
24333-24336	NULL
The	NULL
Ca*	NULL
``	NULL
*+-dependent	NULL
lipid	NULL
binding	NULL
domain	NULL
of	NULL
P120°C*	NULL
``	NULL
mediates	NULL
protein-protein	NULL
interactions	NULL
with	NULL
Ca**-dependent	NULL
membrane-binding	NULL
proteins	NULL
.	NULL

Evidence	NULL
for	NULL
a	NULL
direct	NULL
interaction	NULL
between	NULL
annexin	NULL
VI	NULL
and	NULL
P120C	NULL
``	NULL
.	NULL

Alison	NULL
J.	NULL
Davis	NULL
,	NULL
Jonathan	NULL
T.	NULL
Butt	NULL
,	NULL
John	NULL
H.	NULL
Walker	NULL
,	NULL
Stephen	NULL
E.	NULL
Moss	NULL
,	NULL
and	NULL
Debra	NULL
J.	NULL
Gawler	NULL
The	NULL
initial	NULL
observation	NULL
which	NULL
was	NULL
fundamental	NULL
to	NULL
the	NULL
work	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
was	NULL
originally	NULL
undertaken	NULL
within	NULL
the	NULL
laboratory	NULL
of	NULL
Dr.	NULL
M.	NULL
Moran	NULL
in	NULL
the	NULL
C.	NULL
H.	NULL
Best	NULL
Institute	NULL
,	NULL
Toronto	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
involvement	NULL
of	NULL
Dr.	NULL
Moran	NULL
and	NULL
the	NULL
financial	NULL
support	NULL
of	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
of	NULL
Canada	NULL
are	NULL
grate	NULL
fully	NULL
acknowledged	NULL
.	NULL

The	NULL
telephone	NULL
and	NULL
fax	NULL
numbers	NULL
were	NULL
also	NULL
printed	NULL
incor-rectly	NULL
.	NULL

The	NULL
correct	NULL
numbers	NULL
are	NULL
44-113-2334312	NULL
and	NULL
44-113-2334331	NULL
,	NULL
respectively	NULL
.	NULL

Vol	NULL
.	NULL

271	NULL
(	NULL
1996	NULL
)	NULL
20914-20921	NULL
Characterization	NULL
of	NULL
a	NULL
new	NULL
isoform	NULL
of	NULL
the	NULL
NFAT	NULL
(	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
)	NULL
gene	NULL
family	NULL
member	NULL
NFATe	NULL
.	NULL

Jungchan	NULL
Park	NULL
,	NULL
Atsuko	NULL
Takeuchi	NULL
,	NULL
and	NULL
Surendra	NULL
Sharma	NULL
Page	NULL
20916	NULL
,	NULL
Fig	NULL
.	NULL

1	NULL
:	NULL
We	NULL
recently	NULL
noticed	NULL
that	NULL
the	NULL
published	NULL
NFATc.B	NULL
sequence	NULL
contains	NULL
errors	NULL
at	NULL
two	NULL
nucleotide	NULL
positions	NULL
,	NULL
i.e	NULL
.	NULL

the	NULL
lack	NULL
of	NULL
one	NULL
C	NULL
at	NULL
position	NULL
2334	NULL
and	NULL
the	NULL
lack	NULL
of	NULL
one	NULL
G	NULL
at	NULL
position	NULL
2451	NULL
.	NULL

This	NULL
is	NULL
due	NULL
to	NULL
an	NULL
error	NULL
which	NULL
occurred	NULL
during	NULL
preparation	NULL
of	NULL
Fig	NULL
.	NULL

1	NULL
from	NULL
alignment	NULL
of	NULL
partial	NULL
overlapping	NULL
sequences	NULL
.	NULL

The	NULL
corrected	NULL
sequence	NULL
showing	NULL
an	NULL
additional	NULL
C	NULL
at	NULL
position	NULL
2334	NULL
and	NULL
an	NULL
additional	NULL
G	NULL
at	NULL
position	NULL
2451	NULL
as	NULL
well	NULL
as	NULL
the	NULL
corresponding	NULL
amino	NULL
acid	NULL
changes	NULL
have	NULL
been	NULL
deposited	NULL
in	NULL
GenBank	NULL
``	NULL
with	NULL
the	NULL
accession	NULL
number	NULL
U59736	NULL
.	NULL

Vol	NULL
.	NULL

271	NULL
(	NULL
1996	NULL
)	NULL
7999-8007	NULL
Regulation	NULL
of	NULL
phospholipase	NULL
C-B1	NULL
by	NULL
G	NULL
,	NULL
,	NULL
and	NULL
ml	NULL
muscarinic	NULL
cholinergic	NULL
receptor	NULL
.	NULL

Steady-state	NULL
balance	NULL
of	NULL
receptor-mediated	NULL
activation	NULL
and	NULL
GTPase-activating	NULL
protein-promoted	NULL
deactivation	NULL
.	NULL

Gloria	NULL
H.	NULL
Biddlecome	NULL
,	NULL
Gabriel	NULL
Berstein	NULL
,	NULL
and	NULL
Elliott	NULL
M.	NULL
Ross	NULL
Page	NULL
8001	NULL
:	NULL
The	NULL
first	NULL
complete	NULL
sentence	NULL
is	NULL
incorrect	NULL
.	NULL

The	NULL
correct	NULL
sentence	NULL
is	NULL
shown	NULL
below	NULL
.	NULL

The	NULL
resin	NULL
was	NULL
washed	NULL
as	NULL
follows	NULL
:	NULL
1	NULL
)	NULL
with	NULL
1	NULL
M	NULL
NaCl	NULL
until	NULL
Aggy	NULL
nm	NULL
returned	NULL
to	NULL
zero	NULL
;	NULL
2	NULL
)	NULL
with	NULL
a	NULL
gradient	NULL
of	NULL
1	NULL
NaCl	NULL
to	NULL
1	NULL
m	NULL
NaCl	NULL
plus	NULL
10	NULL
mx	NULL
imidazole	NULL
(	NULL
12	NULL
ml	NULL
)	NULL
;	NULL
3	NULL
)	NULL
with	NULL
1	NULL
m	NULL
NaCl	NULL
plus	NULL
10	NULL
mx	NULL
imidazole	NULL
(	NULL
30	NULL
ml	NULL
)	NULL
;	NULL
4	NULL
)	NULL
with	NULL
a	NULL
gradient	NULL
of	NULL
1	NULL
M	NULL
NaCl	NULL
plus	NULL
10	NULL
mx	NULL
imidazole	NULL
to	NULL
100	NULL
mm	NULL
NaCl	NULL
plus	NULL
10	NULL
mx	NULL
imidazole	NULL
(	NULL
12	NULL
ml	NULL
)	NULL
;	NULL
and	NULL
5	NULL
)	NULL
100	NULL
mx	NULL
NaCl	NULL
]	NULL
plus	NULL
10	NULL
mx	NULL
imidazole	NULL
(	NULL
30	NULL
ml	NULL
)	NULL
.	NULL

Vol	NULL
.	NULL

271	NULL
(	NULL
1996	NULL
)	NULL
22441-22446	NULL
4-Hydroxyphenyl	NULL
retinamide	NULL
activator	NULL
of	NULL
retinoid	NULL
receptors	NULL
.	NULL

is	NULL
a	NULL
highly	NULL
selective	NULL
Andrea	NULL
N.	NULL
Fanjul	NULL
,	NULL
Domenico	NULL
Delia	NULL
,	NULL
Marco	NULL
A.	NULL
Pierotti	NULL
,	NULL
Darryl	NULL
Rideout	NULL
,	NULL
Jian-Qiu	NULL
Yu	NULL
,	NULL
and	NULL
Magnus	NULL
Pfahl	NULL
Page	NULL
22441	NULL
:	NULL
One	NULL
of	NULL
the	NULL
authors	NULL
'	NULL
names	NULL
was	NULL
incorrect	NULL
.	NULL

The	NULL
author	NULL
list	NULL
shown	NULL
above	NULL
is	NULL
correct	NULL
.	NULL

We	NULL
suggest	NULL
that	NULL
subscribers	NULL
photocopy	NULL
these	NULL
corrections	NULL
and	NULL
insert	NULL
the	NULL
photocopies	NULL
at	NULL
the	NULL
appropriate	NULL
places	NULL
where	NULL
the	NULL
article	NULL
to	NULL
be	NULL
corrected	NULL
originally	NULL
appeared	NULL
.	NULL

Authors	NULL
are	NULL
urged	NULL
to	NULL
introduce	NULL
these	NULL
corrections	NULL
into	NULL
any	NULL
reprints	NULL
they	NULL
distribute	NULL
.	NULL

Secondary	NULL
(	NULL
abstract	NULL
)	NULL
services	NULL
are	NULL
urged	NULL
to	NULL
carry	NULL
notice	NULL
of	NULL
these	NULL
corrections	NULL
as	NULL
prominently	NULL
as	NULL
they	NULL
carried	NULL
the	NULL
original	NULL
abstracts	NULL
.	NULL

33705	NULL
Additions	NULL
and	NULL
Corrections	NULL
Vol	NULL
.	NULL

271	NULL
(	NULL
1996	NULL
)	NULL
20914-20921	NULL
Characterization	NULL
of	NULL
a	NULL
new	NULL
isoform	NULL
of	NULL
the	NULL
NFAT	NULL
(	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
)	NULL
gene	NULL
family	NULL
member	NULL
NFATe	NULL
.	NULL

Jungchan	NULL
Park	NULL
,	NULL
Atsuko	NULL
Takeuchi	NULL
,	NULL
and	NULL
Surendra	NULL
Sharma	NULL
We	NULL
reported	NULL
corrections	NULL
at	NULL
two	NULL
nucleotide	NULL
positions	NULL
,	NULL
2334	NULL
and	NULL
2451	NULL
,	NULL
in	NULL
our	NULL
published	NULL
sequence	NULL
of	NULL
NFATeRB	NULL
(	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
33705	NULL
)	NULL
,	NULL
Dr.	NULL
Edgar	NULL
Serfling	NULL
of	NULL
the	NULL
Institute	NULL
of	NULL
Pathology	NULL
,	NULL
University	NULL
of	NULL
Wurzburg	NULL
,	NULL
had	NULL
also	NULL
independently	NULL
identified	NULL
these	NULL
errors	NULL
and	NULL
kindly	NULL
informed	NULL
us	NULL
about	NULL
his	NULL
find-ings	NULL
.	NULL

We	NULL
write	NULL
now	NULL
to	NULL
acknowledge	NULL
his	NULL
personal	NULL
communication	NULL
which	NULL
was	NULL
omitted	NULL
from	NULL
our	NULL
previous	NULL
Additions	NULL
and	NULL
Corrections	NULL
.	NULL

Vol	NULL
.	NULL

272	NULL
(	NULL
1997	NULL
)	NULL
7699-7706	NULL
Characterization	NULL
of	NULL
a	NULL
selective	NULL
antagonist	NULL
of	NULL
neuro-peptide	NULL
Y	NULL
at	NULL
the	NULL
Y2	NULL
receptor	NULL
.	NULL

Synthesis	NULL
and	NULL
pharma-cological	NULL
evaluation	NULL
of	NULL
a	NULL
Y2	NULL
antagonist	NULL
.	NULL

Eric	NULL
Grouzmann	NULL
,	NULL
Thierry	NULL
Buclin	NULL
,	NULL
Maria	NULL
Martire	NULL
,	NULL
Carla	NULL
Cannizzaro	NULL
,	NULL
Barbara	NULL
Dorner	NULL
,	NULL
Alain	NULL
Razaname	NULL
,	NULL
and	NULL
Manfred	NULL
Mutter	NULL
Page	NULL
7699	NULL
:	NULL
Dr.	NULL
Cannizzaro	NULL
's	NULL
name	NULL
was	NULL
misspelled	NULL
.	NULL

We	NULL
suggest	NULL
that	NULL
subscribers	NULL
photocopy	NULL
these	NULL
corrections	NULL
and	NULL
insert	NULL
the	NULL
photocopies	NULL
at	NULL
the	NULL
appropriate	NULL
places	NULL
where	NULL
the	NULL
article	NULL
to	NULL
be	NULL
corrected	NULL
originally	NULL
appeared	NULL
.	NULL

Authors	NULL
are	NULL
urged	NULL
to	NULL
introduce	NULL
these	NULL
corrections	NULL
into	NULL
any	NULL
reprints	NULL
they	NULL
distribute	NULL
.	NULL

Secondary	NULL
(	NULL
abstract	NULL
)	NULL
services	NULL
are	NULL
urged	NULL
to	NULL
carry	NULL
notice	NULL
of	NULL
these	NULL
corrections	NULL
as	NULL
prominently	NULL
as	NULL
they	NULL
carried	NULL
the	NULL
original	NULL
abstracts	NULL
.	NULL

22974	NULL

